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ABSTRACT OF THE DISSERTATION

Brain Enriched microRNAs Open the Neurogenic Potential of Adult Human Fibroblasts
By
Daniel G. Abernathy

Doctor of Philosophy in Biology and Biomedical Sciences
Developmental, Regenerative and Stem Cell Biology
Washington University in St. Louis, 2017
Dr. Andrew S. Yoo, Chair

The seemingly limitless capacities of mammals to sense, respond, and manipulate their
environments stems from their structurally and functionally diverse nervous systems.
Establishing these complex behaviors requires the integration of many biological phenomena
including, morphogenetic gradients, cell-cell signaling, transcriptional networks, cell migration
and epigenetic gene regulation. As mammalian development progresses, these pathways
coordinate the production of highly specialized neuronal and glial cells, that connect and
communicate with another in an even more complex manner. While evolution has shaped a
multitude of pathways to produce numerous favorable traits, it has also created an intricate
system vulnerable to disease. The loss of different types of neurons, each responsible for
specialized biochemical communications within the brain and spinal cord, results in a wide
x

variety of neurological and neurodegenerative diseases. Unfortunately, many of these diseases
are uniquely human and cannot be wholly studied in model organisms such as Mus musculus or
Drosophila melanogaster. Further, their location and absolute necessity precludes isolation
directly from patients. Fortunately, advances in our understanding of genetic pathways that
specify neuronal cell fates during development have enabled the directed differentiation of
embryonic and induced pluripotent stem cells (iPSCs) into specific neuronal subtypes. This
knowledge has been further leveraged to directly convert (reprogram) non-neuronal somatic cells
into neurons, bypassing the induction of pluripotency. Specifically, ectopically expressing small
non-coding microRNAs (miRNAs), miR-9/9* and miR-124 (miR-9/9*-124), with transcription
factors in human adult fibroblasts is sufficient to generate functionally mature neuronal subtypes.
These direct conversion modalities may prove invaluable in the study of late-onset
neurodegenerative diseases, as the original age of human fibroblasts is maintained in converted
neurons in contrast to the cellular rejuvenation observed in iPSCs. However, little is known
about the epigenetic and molecular events that accompany direct cell-fate conversion limiting the
utility of these features. Further, the capacity of miRNAs alone to overcome cell fate barriers has
largely been unexplored. Within this thesis I provide mechanistic insights into the cell-fate
pioneering activity of miR-9/9*-124. These results demonstrate that miRNAs induce remodeling
of chromatin accessibilities, DNA methylation and the transcriptome leading to the generation of
functionally excitable neurons. Surprisingly, during neuronal reprogramming, miR-9/9*-124
opens neuronal gene loci embedded in heterochromatic regions while simultaneously repressing
fibroblast loci, revealing how miRNAs may overcome the cell-fate barrier that exists in human
fibroblasts. These findings led to the discovery of a miRNA-induced permissive neurogenic
ground state capable of generating multiple, clinically relevant neuronal subtypes. As such, I

xi

show that the addition of motor neuron factors, ISL1 and LHX3, can function as terminal
selectors to specify neuronal conversion to a highly enriched population of human spinal cord
motor neurons. Altogether, the work contained within this thesis identifies miRNA-mediated
epigenetic remodeling events underlying direct neuronal conversion of human fibroblasts and a
modular platform capable of generating multiple, clinically relevant neuronal subtypes directly
from patients.
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Abstract
The specification of multipotent stem cells to defined cell types requires complex
integrations of genetic pathways. During neurogenesis - the process of generating functional
neurons from neural progenitor cells - many genetic and epigenetic processes play a critical role
in regulating genes that control the proliferation and differentiation of neural progenitor cells.
MicroRNAs (miRNAs) in particular, play an important role upstream of neurodevelopmental
processes by modulating the expression of genes that alter chromatin states. During neural
development, miRNAs, particularly brain enriched miR-9/9* and miR-124, regulate
neurogenesis by targeting many key epigenetic pathways that affect the transcriptional
accessibility of chromatin regions as well as mRNA processing. Importantly, ectopic expression
of miR-9/9* and miR-124 in human fibroblasts induces the cells to adopt a neuronal fate. Direct
conversion of a non-neuronal somatic cell to a functional neuron by brain-enriched miRNAs not
only emphasizes the essential role of miRNAs in neurogenesis, but also provides new strategies
for modeling human neurodegenerative diseases and regenerative medicine.
Key words: neurogenesis, epigenetics, miRNA, reprogramming, REST complex, BAF complex,
PTBP
Introduction
Development of the mammalian nervous system results from the combinatorial action of
morphogenetic gradients, cell-cell signaling, transcriptional networks, and cell migration (Götz
and Huttner, 2005). The output of this intricate regulatory network is a collection of
interconnected neural cells comprised of glia and neurons. These two cell types can be
2

subdivided further into distinct, highly specialized cells. In addition to developmental programs
governed by transcription factors, non-coding RNAs facilitate neural fate acquisition (Cao et al.,
2006; Cochella and Hobert, 2012; Pauli et al., 2011; Sun et al., 2013). The most widely
characterized are small 20-24 nucleotide long microRNAs (miRNAs) that coordinate gene
expression at the post-transcriptional level (Bartel, 2009; Krol et al., 2010; Pasquinelli, 2012)
through translational inhibition and mRNA decay (Bartel, 2009; Bazzini et al., 2012; Djuranovic
et al., 2012; Pasquinelli, 2012). These short stretches of RNA can have marked effects on gene
networks as a single miRNA can target hundreds of mRNAs (Bernstein et al., 2003; Chi et al.,
2009; Peter, 2010). Furthermore, multiple miRNAs can target a single transcript, dramatically
increasing the effect on single gene expression (Wu et al., 2010). These properties enable
miRNAs to act in both feedforward and feedback loops (reviewed in Ebert and Sharp, 2012) in
order to establish developmental transitions, cell fate switches, and to refine gene expression.
miRNAs have been shown to be an integral part of transcriptional networks that drive
developmental programs. The importance of miRNAs in many aspects of neural development
has been reviewed elsewhere (Cao et al., 2006; Cochella and Hobert, 2012; Pauli et al., 2011;
Sun et al., 2013) and in this issue. Here, we discuss studies that have increased our understanding
of the activities of miRNAs during neuronal differentiation. We then focus on how genetic
programs rely on specific miRNAs to reinforce transcriptional programs during neural
development through feedback and feedforward genetic networks. Identification of genetic
pathways from neural developmental studies has led to the ability to differentiate neurons from
embryonic and induced pluripotent stem cells and recently, reprogram non-neuronal cells into
neurons (reviewed in Morris and Daley, 2013), demonstrating the necessity to understand how
miRNAs contribute in cell fate decisions during neural development.
3

miRNAs in Development
The major path to a mature miRNA begins in the nucleus where RNA polymerase II
transcribes a primary miRNA transcript (pri-miRNA) that ranges in length, but is generally
around several hundred base pairs (Lee et al., 2002). The pri-miRNA is processed down to a 60100 nucleotide precursor hairpin (pre-miRNA) by Drosha and its cofactor DGCR8 (Bartel, 2009;
Krol et al., 2010; Pasquinelli, 2012). The intermediate pre-miRNAs are transported into the
cytoplasm by Exportin 5 where they are cleaved into their mature 19-25 nucleotide form by
Dicer. Mature miRNAs are loaded into the RNA induced silencing complex (RISC) that, in
complex with Argonaute (Ago) proteins, typically targets the 3’UTR of mRNAs. This leads to
either translational repression or mRNA degradation (Bartel, 2009; Bazzini et al., 2012;
Djuranovic et al., 2012; Pasquinelli, 2012).
Initial investigations into the role of miRNAs in development were based on disruption of
miRNA biogenesis. With the observation that whole mouse embryo Dicer knockouts die at E7.5,
many groups focused on generating tissue-specific Dicer deletion strains using Cre expression
(Bernstein et al., 2003). Although the role of specific miRNAs acting through canonical miRNA
biogenesis cannot be assessed using this strategy, it has revealed interesting facets of miRNAs in
general and their role during neural development. Notably, proper migration, differentiation, and
integration of neurons during neurogenesis requires mature miRNAs (Bernstein et al., 2003;
Kawase-Koga et al., 2009; Makeyev et al., 2007; Volvert et al., 2012). Deleting Dicer in the
telencephalon during neural development using a FoxG1-Cre line resulted in increased apoptosis
culminating in a thinner cortical plate (Makeyev et al., 2007). Although there appears to be no
effect on differentiation, the stereotyped organization of the cortex is disrupted. Further refining
Dicer ablation in the cortex through the use of a Emx1-Cre driver yields analogous results, but
4

cortical defects appear earlier in development (De Pietri Tonelli et al., 2008). Similarly, deleting
Dicer in neural progenitors using Nestin-Cre results in increased apoptosis, reduced cortical
thickness, and increased ventricular volume (Kawase-Koga et al., 2009).
FoxG1 and Emx1 are restricted rostrally with Emx1 being the most cortical specific, yet
in terms of cortical defects, these two Cre-drivers lead to earlier cell death and premature
neuronal differentiation when compared to the Nestin-Cre driver. This is surprising since Nestin
is expressed in all neural progenitors. Kawase-Koga and Sun attribute this difference to the
timing of Dicer deletion, as opposed to cell types. Delineating the miRNAs responsible for the
myriad of phenotypes observed in Dicer knockouts has previously been technically unfeasible.
Now, we are able to examine specific miRNA-target networks at a global level, which has
facilitated the dissection of miRNA-dependent biological processes.
Identification of miRNAs enriched in the nervous system
Advances in sequencing technology within the past 10 years have greatly increased the
detectability of specific miRNAs and their targets within a select population of cells. These
techniques have also shifted several commonly accepted notions of miRNA-mediated regulation
by demonstrating binding outside the 3’UTR (Lee et al., 2009; Lytle et al., 2007; Ørom et al.,
2008), localization of functioning miRNAs in the nucleus (Buckley et al., 2012; Jeffries et al.,
2011; Khudayberdiev et al., 2013) and lastly bypassing the requirement of the 5’ seed regions
(Boudreau et al., 2013; Chi et al., 2012; Helwak et al., 2013). Collectively, these studies reveal a
wider network of target genes and further emphasize the importance of miRNAs in gene
regulation.
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Identifying a collection of miRNAs and their targets has been accomplished primarily
through target prediction algorithms, crosslinking techniques such as HITS-CLIP and PARCLIP, Ago-HITS-CLIP, and miRNA microarrays (Chi et al., 2009; Hafner et al., 2010; Liu et al.,
2004; Ule et al., 2005). Each of these tools generates hundreds of possible miRNAs and targets
that must be further validated. Nonetheless, they have revealed changes in miRNA expression as
the brain develops and have identified many targets that mediate developmental transitions and
neuronal function, including widely characterized miRNAs, miR-124, miR-9, miR-125, miR-132
and the let-7 families (Cochella and Hobert, 2012). In addition, these techniques can be applied
to post-mortem human samples thus enabling the identification and validation miRNAs-mRNA
interactions within the human brain (Boudreau et al., 2013), allowing comparisons of miRNA
expression and target recognitions in different species.
Boudreau et al. observed a marked difference in the conserved binding sites between
mouse and human brains (Boudreau et al., 2013). While the authors note the methods used to
collect and determine the mouse data could have caused this difference, others have
hypothesized that miRNAs are strong contributors to brain evolution and cognition (Bentwich et
al., 2005; Hu et al., 2011; Lukiw, 2012) suggesting that the difference between mouse, primate
and human miRNA expression may have biological meanings.
Further refinement of miRNA and target expression analysis through the expression of
tagged-Ago proteins has enabled miRNA profiling in specific neuronal subtypes. Given the
potent effects miRNAs have on both neurogenesis and neuronal function, determining the cell
specific miRNA expression profile within neurons is fundamental to understanding their
development (Hobert et al., 2010; Sempere et al., 2004). He et al. characterized the miRNA
expression profile of five neuronal subtypes within the brain and revealed that glutamatergic,
6

GABAergic, and subclasses of GABAergic neurons within the neocortex and cerebellum,
respectively, contain distinct but overlapping miRNA expression profiles (He et al., 2012). For
example, parvalbumin (PV) and somatostatin (SST) expressing GABAergic interneurons overlap
in miR-124 and miR-9 expression while SST interneurons express miR-187 and miR-551b at a
level 6-fold higher than PV interneurons. Similarly, Camk2α neurons in the neocortex express
miR-296 and miR-130b significantly more than Gad2 neurons from the same neuronal
compartment. It is important to note that over 100 miRNAs were shown to have significant
differential expression between sub-type comparisons. Interestingly, the authors also observed
cell-type specific miRNA strand selection from precursors within different neuronal subtypes
which could provide alternative target selection. So far, the exact role of miRNAs enriched in
different neuronal subtypes largely remains unknown.
Function of miRNAs in Early Neural Development
Once dorsal ectoderm is specified to become neuroectoderm through BMP and activin
inhibition and increased Wnt and FGF signaling the central nervous system starts to take shape
(Stern, 2005). The appearance of the neural plate and formation of the neural folds dorsal to the
neural plate provides the framework for cell specification. Positional information along rostrocaudal and dorso-ventral axis of the neural tube has been shown to demarcate future cell fate
largely through the action of ventral Shh, dorsal BMP and rostro-caudal retinoic acid gradients
(Jessell, 2000; Stern, 2005). The mechanism that establishes progenitor domains along these axis
relies on a combinatorial code of morphogenetic gradients and transcription factor networks (for
review see Jessell, 2000). Many components of the transcriptional and signaling components
necessary for proper motor neuron pattern formation have been well characterized. Recent
evidence suggests that miRNAs also play important roles in regulating the balance between
7

cross-repressive transcription factors within the neural tube. miR-196, miR-17-3p and miR-9
appear to provide boundary information within the developing spinal cord by refining
transcription factor networks during motor neuron specification (Asli and Kessel, 2010; Bonev et
al., 2011; Chen et al., 2011). Interestingly, the biological role of each of these miRNAs during
neurogenesis differs spatially and temporally along the developing embryos’ axis, suggesting
that miRNAs can have diverse functions within neurons depending on the milieu of mRNAs they
encounter. For instance, the combinatorial action of multiple miRNAs can result in stronger gene
repression leading to greater changes within genetic networks (Wu et al., 2010). Therefore,
regionally specific miRNAs could coordinate specific programs of neural development. Further
studies integrating spatially and temporally expressed miRNAs within the nervous system may
provide insights into the generation of neuronal diversity.
Despite different biological outputs, miRNAs both inside and outside of the nervous
system have been consistently identified has key mediators of both feedforward and feedback
loops. Here, the repressive activity of miRNAs can act both to activate or inhibit gene
expression. The redundancy built in these systems is thought to provide robustness to genetic
networks (Ebert and Sharp, 2012). Below, we review evidence demonstrating the importance of
miRNAs in enforcing genetic programs through feedforward and feedback loops during cortical
neuron development, one of the most characterized neural fate programs.
Feedback Inhibition During Cortical Neurogenesis
miR-9, one of the most widely studied neuronal miRNAs participates in a wide variety of
neuronal differentiation programs (Coolen et al., 2013; Kapsimali et al., 2007). It plays a vital
role in the differentiation of neural progenitors into post-mitotic neurons by modulating a host of
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targets (reviewed in Coolen et al., 2013). Within the developing forebrain, the orphan nuclear
receptor TLX maintains neural stems cells in a proliferative state through activation of Wnt/ßcatenin and recruitment of histone deacetylases that repress the loci of p21 and PTEN (Qu et al.,
2010; Sun et al., 2007). Suppression of TLX expression in neural stem cells by miR-9 leads to
decreased proliferation, premature differentiation, and migration toward the cortical plate (Zhao
et al., 2009). It is thought that during normal development this repressive interaction regulates
the differentiation of cortical progenitors. Premature differentiation is prevented at least in part,
by the repression of miR-9 by TLX (Zhao et al., 2009). Others have also shown that processes
mediated by miR-9 can be attributed to several targets within the cortical progenitor pool
(Shibata et al., 2011). This negative feedback loop is further strengthened by additional miRNAs
and targets of miR-9. For example, TLX expression is repressed during neurogenesis by let7b
(Zhao et al., 2010). miR-137, also highly expressed in the brain, targets LSD1, a co-repressor
that acts in conjunction with TLX to mediate transcriptional repression (Sun et al., 2011). This
indicates that the effects of these miRNAs, when expressed together, may have a more dramatic
phenotype than previously reported. The negative feedback loops present during cortical
neurogenesis are depicted in Fig1. It is interesting to note that in each of these studies, overexpression of these miRNAs individually caused remarkably similar phenotypes and the
expression of a single target often mitigated these effects. In addition, it is unknown if this
regulatory relationship can be extended outside the cortical compartment. While miR-9 is
expressed throughout the vertebrate nervous system (Lagos-Quintana et al., 2002), the pool of
target mRNAs and co-repressive miRNAs could vary between neuronal populations. The ability
of pan neuronal miRNAs to function differently within different neuronal populations remains an
open question.
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In the case of cortical neuron specification and differentiation, miRNAs clearly integrate
into known genetic pathways, providing additional information to the developing nervous
system. However, their relationship to one another and the network as a whole remains unclear.
If miR-9, miR-137, and let7d have overlapping expression patterns, it is possible that they share
common targets and their effect on cell fate is more pronounced than previously reported. Such
synergy has been clearly demonstrated with the brain enriched miRNAs miR-9/9* and miR-124
(miR-9/9*-124) in chromatin regulation as described below.
miRNAs and Epigenetic Regulation
During development, ATP-dependent chromatin remodeling complexes acquire new
activities by altering their subunit compositions (Ronan et al., 2013). Differentiation of neural
progenitors into neurons is accompanied by a switch in the subunit composition of the
mammalian SWI/SNF (BAF) chromatin remodeling complex. Specifically, subunits present in
neural progenitors are exchanged with the neuron specific BAF45B/C, CREST, and BAF53b
subunits (Lessard et al., 2007; Staahl et al., 2013; Wu et al., 2007). miR-9/9* and miR-124,
regulate this switch by targeting the 3’ UTR of BAF53a and prolonged expression of BAF53a in
vivo represses BAF53b expression suggesting that miR-9/9*-124 expression initiates a
feedforward loop that culminates in the swap of subunits within the BAF complex (Yoo et al.,
2009). The onset of this regulatory cascade is instigated through a negative feedback loop
between miR-9/9*-124 and the RE1 silencing transcription factor (REST/NRSF) complex
(Conaco et al., 2006; Packer et al., 2008).

10

Figure. 1 miRNA-dependent negative feedback loops in cortical neurogenesis. As cortical
progenitors differentiate into cortical neurons the expression of miR-9 and miR-137 is induced
leading to the direct repression of the orphan nuclear receptor TLX. The expression of miR-9 and
miR-137 is normally repressed in cortical progenitors by TLX. This negative feedback loop is
further reinforced by the repression of LSD1, a co-repressor that acts in concert with TLX, by
miR-137.

REST/NRSF was initially identified as a neuronal repressor that prevents the expression
of neuronal genes outside the nervous system (Chong et al., 1995; Schoenherr and Anderson,
1995). This repressive activity is attained by recruiting other co-repressors such as co-REST,
SCP1, MeCP2, and histone deacetylases (Andrés et al., 1999; Lunyak, 2002; Roopra et al., 2000;
Yeo, 2005). As neural progenitors differentiate into post-mitotic neurons, REST/NRSF-mediated
repression is relieved upon the inhibition of REST/NRSF expression (Ballas et al., 2005).
Interestingly, REST/NRSF and co-REST have been shown to be regulated by miR-9 and miR11

9*, respectively (Packer et al., 2008). The sharp contrast in REST/NRSF expression between
neuronal and non-neuronal cells is maintained through mutual repression between miR-9 and
REST/NRSF. This negative feedback loop contributes to the neuronal specific expression of
miR-9/9*-124 as all the active loci of miR-9/9* and miR-124 are occupied by REST/NRSF in
non-neuronal cells (Conaco et al., 2006). In addition, SCP1, a component of the REST/NRSF
silencing complex that facilitates neuronal silencing, was shown to be targeted by miR-124
(Visvanathan et al., 2007).
The loss of REST/NRSF-mediated repression and concomitant upregulation of neuron
specific gene expression is also accompanied by neuron specific splicing events (Li et al., 2007).
Makayev et al., observed that when miR-124 was overexpressed in two neuroblastoma cell lines
they adopted a neuron-like morphology and contained neuron-specific alternatively spliced
transcripts (Makeyev et al., 2007). They showed that the downregulation of the splicing repressor
PTBP1 by miR-124 leads to neuronal specific splicing events including the production of
PTBP2, a neuron-specific splicing regulator that is normally excluded from non-neuronal cells
by PTBP1 (Boutz et al., 2007). Here, the reciprocal expression of PTBP1 and PTBP2 is initiated
by miR-124 creating both a feedforward and feedback loop. A summary of the miR-9/9*-124
dependent regulatory circuit is shown in Figure 2.
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Figure 2. miR-9/9*, miR-124 and REST coordinate neurogenesis through multiple positive
and negative feedback loops. REST silences many neuronal genes including miR-9/9* and
miR-124. At the onset of neural differentiation, miR-9/9* and miR-124 are upregulated leading
to the repression of their targets, REST, BAF53a and PTBP1. REST, co-REST, and SCP1
repress miR-9/9* and miR-124 which creates a feedback loop allowing for distinct, reciprocal
expression patterns. BAF53a normally inhibits BAF53b, the relief of this repression by miR-9/9*
and miR-124 enables BAF53b expression and formation of neuron specific BAF chromatin
remodeling complex which is important for proper dendritic outgrowth. This feedforward loop is
distinct from PTBP1’s repression by miR-124. Here, neuron specific splicing is accomplished by
repression of one splicing repressor, PTBP1, which directly represses the expression of another
splicing regulator PTBP2. During neurogenesis, the expression of miR-9/9* and miR-124 that
13

are activated at least in part by dismissal of REST binding leads to a cascade of genetic events
that strongly re-enforces the neurogenic program
Negative feedback loops are continually being characterized between miRNAs and their
repressors, and the sum of these feedback loops can have dramatic effects when the balance is
sharply tipped in one direction. For instance, ectopic expression of miR-9/9*-124 directly
converts human fibroblasts into post-mitotic neurons (Figure 3) (Yoo et al., 2011). While neither
miRNA alone is capable of reprogramming the human fibroblasts, the neuronal conversion can
be enhanced with the addition of neuronal transcription factors, revealing a synergy between
multiple miRNAs and pro-neural transcription factors. The observation that miRNAs alone are
capable of switching cell fate demonstrates their potency in regulating neuronal gene networks.
Others have also taken advantage of manipulating the genetic circuit involved in neuronal
specific splicing to achieve neuronal reprogramming (Xue et al., 2013).
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Figure 3. Neuronal conversion of primary human dermal fibroblasts mediated by miR9/9*-124. Pictures depict (A) human neonatal fibroblasts and (B) converted cells immunostained
with a pan-neuronal marker, MAP2 (adapted from Yoo et al., 2011).

Asymmetric Cell Division and Neuron Specific miRNA Activity
One of the large outstanding questions in mammalian neurogenesis is how asymmetric
division of neural stem cells is regulated. Recently Schwamborn et al, uncovered that TRIM32, a
TRIM NHL protein, is asymmetrically inherited during neural progenitor division (Schwamborn
et al., 2009). The daughter cell that does not receive TRIM32 remains a neural progenitor while
the daughter inheriting the TRIM32 protein differentiates into a neuron. The mechanism behind
this differentiation is due to two separate activities performed by TRIM32. As a ubiquitin ligase
TRIM32 tags c-Myc for degradation. Repression of c-Myc leads to cell cycle exit and further
participates in neural induction. Secondly, TRIM32 complexes with Ago1 leading to enhanced
activity of several pro-neural miRNAs. One of these miRNAs, let7a, contributes to neural
differentiation although not to the extent of TRIM32. Others have also shown let7a has both antiproliferative effects and is upregulated during neurogenesis (Peng et al., 2008; Rybak et al.,
2008). The effect(s) of TRIM-32 on other pro-neural miRNAs remains unexplored.
Conclusion
Much like transcription factors, miRNAs can exist in feedback loops with their repressors
or activators enabling binary switches and signal amplification, respectively. The cumulative
effect of each regulatory node described thus far results in the vast array of highly specialized
cells within the nervous system that connect and communicate in an even more complex manner.
15

Our understanding of the development of specific types of neurons has been limited to the
transcription factors necessary for the development of these populations. The advent of new
technologies enables mechanistic studies focusing on the function of specific miRNAs during the
development, and subsequent maintenance of neuronal subtypes. Further understanding of the
genetic networks that connect each of these pathways within a single cell–type will greatly
facilitate our understanding of neural development. To date, much progress has been made in
understanding miRNAs and target interactions in neurogenesis. The results described here are a
group of select studies that demonstrate both the importance of miRNA-dependent genetic
networks and the need to connect this accumulated knowledge.
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Abstract
Neuronal microRNAs, miR-9/9* and miR-124 (miR-9/9*-124) direct cell-fate conversion
of adult human fibroblasts to post-mitotic neurons and with additional transcription factors
enable the generation of discrete neuronal subtypes. Previously, the molecular events
underlying the neurogenic switch mediated by microRNAs during neuronal reprogramming were
unknown. Here, we systematically dissected the neurogenic state induced by miR-9/9*-124
expression alone. We found that miR-9/9*-124 surprisingly stimulate reconfiguration of
chromatin accessibility, DNA methylation and mRNA levels, leading to the generation of
functionally excitable miRNA-induced neurons (miNs) that are yet uncommitted towards a
particular subtype-lineage. Further subtype identity can be programmed through additional
transcription factors. As such, we show ISL1 and LHX3 selectively commit conversion to a
highly homogenous population of human spinal cord motor neurons (Moto-miNs). Taken
together, our study reveals a modular synergism between microRNAs and transcription factors
that allows lineage-specific neuronal reprogramming, providing a platform for generating distinct
subtypes of human neurons.

INTRODUCTION
Understanding genetic pathways that specify neuronal cell fates during development has
enabled directed differentiation of pluripotent stem cells to specific neuronal subtypes (Perrier et
al., 2004; Wichterle et al., 2002). This knowledge has been further leveraged to directly convert
(or reprogram) non-neuronal somatic cells into neurons via ectopic expression of pro-neural
transcription factors (TFs) or neurogenic miRNAs with TFs (Mertens et al., 2016). These direct
conversion modalities may prove invaluable in the study of late-onset neurodegenerative
diseases, as the original age of human fibroblasts is maintained in converted neurons (Huh et
al., 2016; Mertens et al., 2015) in contrast to the cellular rejuvenation observed in induced
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pluripotent stem cells (Horvath, 2013; Miller et al., 2013). Interestingly, the miRNA-mediated
reprogramming approach boasts high conversion efficiency in adult human fibroblasts, which
may provide unique opportunities in modeling neurological disorders using patient derived
neurons (Victor et al., 2014). However, despite the advantages of direct reprogramming, little is
known about the epigenetic and molecular events that accompany direct cell-fate conversion.
MiRNAs regulate genetic pathways by binding to their target transcripts and repressing
their expression (Pasquinelli, 2012). Target specificity is governed largely through short
sequence complementarity within the 5’ end of a miRNA enabling a single miRNA to target
hundreds of mRNA transcripts (Boudreau et al., 2014; Chi et al., 2009). Moreover, a single
mRNA can be targeted by multiple miRNAs, markedly enlarging the effect on single gene
repression (Wu et al., 2010). The convergence of genetic controls by miRNAs towards a specific
biological process is exemplified by miR-9/9* and miR-124 miRNAs activated at the onset of
neurogenesis (Conaco et al., 2006; Makeyev et al., 2007). For example, miR-9* and miR-124
synergistically initiate subunit switching within BAF chromatin remodeling complexes (Staahl et
al., 2013; Yoo et al., 2009) while separately repressing the neuronal cell-fate inhibitors REST,
Co-REST and SCP1 (Packer et al., 2008; Visvanathan et al., 2007). These examples suggest
that miR-9/9* and miR-124 target components of genetic pathways that antagonize
neurogenesis to promote a neuronal identity during development.
Co-expressing miR-9/9* and miR-124 (miR-9/9*-124), with TFs enriched in the cortex
and striatum directly converts primary adult human fibroblasts to cortical and striatal medium
spiny neurons, respectively (Victor et al., 2014; Yoo et al., 2011). However, the same TFs
without miR-9/9*-124 fail to trigger neuronal conversion (Victor et al., 2014; Yoo et al., 2011),
suggesting that the miRNA-induced neuronal state is permissive to terminal selector TFs which,
upon determination of a neuronal fate, initiate and advance mature subtype-identities
(Stefanakis et al., 2015).
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Here, we systematically investigated a miRNA-induced neuronal state in adult human
cells. Longitudinal analyses of the transcriptome, genome-wide DNA-methylation and chromatin
accessibilities revealed that miR-9/9*-124 induced extensive remodeling of the epigenome,
including simultaneous activation of a pan-neuronal program and the reconfiguration of
chromatin accessibilities. These changes precede the emergence of differentially methylated
genomic regions. Because miR-9/9*-124 also led to the opening of genomic loci for multiple
subtype-specific genes including established motor neuron markers, we postulated that motor
neuron-enriched transcription factors would cooperate with miR-9/9*-124 to specify a motor
neuron lineage. As such, we demonstrate that co-expressing TFs ISL1 and LHX3 along with
miR-9/9*-124 generated a highly pure population of human spinal cord motor neurons. Taken
together, these results demonstrate that miR-9/9*-124 opens the neurogenic potential of adult
human fibroblasts and provides a platform for subtype-specific neuronal conversion of human
cells.
RESULTS
Neuronal Conversion of Human Adult Fibroblasts With miR-9/9*-124 Alone
To dissect how miRNAs alone contribute to neuronal conversion, we first tested the
ability of miR-9/9*-124 to convert primary human fibroblasts collected from multiple adult
individuals from ages 22 to 68 into microRNAs-induced neurons (miNs). We transduced
fibroblasts with lentivirus containing a doxycycline (Dox)-inducible promoter driving miR-9/9*124 and BCL-XL expression (Victor et al., 2014) (Figures 1A and S1A). At 35 days posttransduction, we evaluated cell morphology and the expression of neuronal markers MAP2,
TUBB3 and NEUN by immunocytochemistry (Figure 1B). Strikingly, miR-9/9*-124 alone
converted 80% of the fibroblasts to neuronal cells displaying complex neurite outgrowth and
neuronal marker expression (Figures 1B and 1C). The converted cells stained positive for
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voltage-gated sodium channels SCN1A and Ankyrin G, which localized at axonal initial
segments with a characteristic polarized staining pattern (Figure 1D). The synaptic vesicle
marker SV2 displayed defined puncta along neurites, consistent with the adoption of a neuronal
fate (Figure 1D).
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Figure 1. Direct Conversion of Young and Old Primary Adult Human Fibroblasts into
Neurons via miRNA Overexpression.
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(A) Experimental schema for miR-9/9*-124 mediated direct neuronal conversion.
(B) Adult human fibroblasts ectopically expressing miR-9/9*-124 for 35 days immunostained for
the pan-neuronal markers TUBB3, MAP2 and NEUN. Insets represent starting fibroblasts costained as negative controls. Scale bars = 20µm.
(C) Quantification of TUBB3, MAP2 and NEUN positive cells over total number of cells (DAPI).
For TUBB3 and MAP2, only cells with processes at least three times the length of the soma
were counted. For NEUN, only cells with proper nuclear localization were counted. Data are
represented as mean ± SEM. 22 Yr Female n = 238 cells, 42 Yr Female, n = 100 cells, 56 Yr
Male n = 171 cells, and 68 Yr Female n = 216.
(D) Converted neurons display hallmark sodium channel (SCN1A), axonal initial segment
(ANKG) (left) and synaptic vesicle (SV2) (right) staining patterns. Scale bars = 20µm.
(E) Representative traces of TTX-sensitive inward and potassium whole-cell currents.
(F) Repetitive AP waveforms in response to 500 ms current injections recorded from neurons
converted in monoculture.
(G) Summary of firing patterns observed in 23 neurons recorded in current-clamp mode (left)
and representative waveforms within each firing pattern recorded (right).
See also Figure S1.
Functional Properties and Stability of MiRNA-induced Neurons
To determine if miNs displayed membrane excitability, we performed whole-cell
recording on miNs without glial co-culture. All cells recorded (23/23 cells) exhibited fast TTXsensitive inward currents upon depolarization (Figure 1E, while 19/23 cells fired action
potentials (APs) during current injections (9 cells fired multiple APs, 10 fired single APs)
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(Figures 1F and 1G). Similar current (I)-voltage (V) curve relationships were observed between
cells that fired multiple or single action potentials (Figure S1B). All miNs had a stable
hyperpolarized resting membrane potential ranging from -52.7 to -84.5 mV with a mean value of
-69.63 mV ± 2.15 mV (S.E.M.) (Figures S1C and S1D). There was no correlation between
capacitance and firing patterns suggesting this membrane property is not as an accurate
measure of neuronal maturation (Figure S1E). Together, this data indicates that miNs exhibit
the membrane functionality of neurons.
The minimum duration of miRNA expression required for neuronal conversion was
determined by inactivating the doxycycline-inducible promoter at 3-day intervals by Dox removal
beginning at day 9 until reprogramming day 30 (Figure S1F). Loss of fibroblast identity and gain
of neuronal identity was assayed by analyzing fibroblast-specific protein (FSP1) and MAP2
expression, respectively. Surprisingly, we saw a reduction in the number of FSP1-positive cells
and the appearance of MAP2-positive cells after only 9 days of miRNA expression, however;
efficient switching of a cell population from FSP1- to MAP2+ required 30 days of miR-9/9*-124
expression (Figure S1F). These data reveal the non-synchronous process of the neuronal
conversion and temporal requirements for highly efficient neuronal conversion. The stability of
miRNA-induced neuronal conversion was determined by following miNs for an additional 30
days after removing miR-9/9*-124 exposure (Figure S1G, top). The majority of miNs remained
as post-mitotic neurons (marked by the absence of Ki67, a cell proliferation marker) expressing
MAP2, TUBB3, NeuN and NCAM, in contrast to non-converted fibroblasts (Figure S1G, left
panel), indicating that the morphological and protein expression changes that accompany miR9/9*-124-mediated conversion of adult human fibroblasts are stable after 30 days of miR-9/9*124 expression.
Transcriptional Profiling of miNs
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To further explore the miR-9/9*-124-mediated neuronal output, we profiled the
transcriptome of starting human adult fibroblasts and miNs after 30 days of neuronal conversion
by RNA-Seq. We identified 2,692 differentially expressed genes (DEGs) in miNs representing
1,251 up-regulated and 1,441 down-regulated genes in comparison to fibroblasts (log fold
change ≥ 2 ; adj.P-value <0.01) (Figure 2A). A robust down-regulation of fibroblast-specific
genes (for instance, S100A4, VIM, FBN1 and, COL13A1) was accompanied an enrichment of
pan-neuronal genes including MAP2, SCN1A, SNAP25, NRCAM, and NEFM (Figure 2A, 2B top
two traces). Analysis of top 10 gene ontology (GO) terms revealed that upregulated genes in
miNs are primarily enriched with terms related to neuronal development and functionality
(Figure 2C) while down-regulated genes associate with fibroblast functions (Figure 2C). Downregulated genes also included key cell-cycle components (data not shown), consistent with the
previous finding that miR-9/9*-124 expression in human fibroblasts caused rapid cell cycle exit
without transitioning through a neural stem cell-like state (Yoo et al., 2011). Interestingly,
neuronal subtype-specific genes such as TH (dopaminergic neurons), GABBR2, GABR1, and
GAD2 (GABAergic neurons), CHAT (cholinergic neurons), or DARPP-32 (striatal medium spiny
neurons), were not significantly enriched in miNs (Figure 2B, bottom two traces as examples).
Overall, our transcriptome analyses show that miR-9/9*-124 induce a neuronal state
characterized by the loss of fibroblast identity and the presence of a pan-neuronal gene
expression program without commitment to a particular subtype.
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Figure 2. Gene Expression Profiling Reveals Pan-Neuronal Identity Induced by miRNAs
Alone
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(A) Genome wide expression analysis of miNs and starting fibroblasts by RNA-seq. Plot shows
the relationship between average gene expression (logCPM) and log fold-change of miNs
compared to fibroblasts. A selection of pan-neuronal and fibroblast-specific genes are
highlighted in black text. Blue = fold change <-2 log2 p<.01 (more abundant in fibroblasts), grey
= fold change >-2 log2<2 log2 p>.01, and red = fold change>2 log2 p<.01 (more abundant in
miNs). FDR <.01.
(B) Representative genome browser snapshots demonstrating increased expression for a panneuronal gene (NEFL), loss of fibroblast marker gene expression (S100A4), and absence of
neuronal subtype marker gene expression (MNX1, motor neuron marker; DARPP-32, medium
spiny neuron marker).
(C) Gene ontology (GO) terms associated with genes upregulated in miNs (red) and GO terms
associated with genes downregulated in miNs (blue). Right, genes that fall within top GO
categories listed (top to bottom) in order of lowest to highest p-value.
(D) Volcano plot representing chromatin remodeling genes differentially expressed between
fibroblasts and miNs. Blue dot, abs(logFC) > 2 and p < 0.01, red dot, abs(logFC) > 1 and p <
0.01, grey dot, no significant difference.
See also Figure S2.
Transcriptional Changes in Epigenetic Machinery
Epigenetic modifications can markedly affect gene expression and developmental
programs (Cantone and Fisher, 2013). Our gene expression studies showed that when
compared to fibroblasts, miNs had markedly altered expression of genes involved in DNA
methylation, histone modifications, chromatin remodeling and chromatin compaction (Figures
2D and S2). For instance, the TET family of proteins, key mediators of DNA-demethylation (Wu
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and Zhang, 2011) were upregulated along with the brain-enriched de novo DNAmethyltransferase DNTM3A (Lister et al., 2013), while DNMT3B (Okano et al., 1999) mRNA
levels were reduced in miNs compared to fibroblasts (Figures 2D and S2). Transcripts encoding
histones and histone variants were altered (Figure S2) suggesting that changes in histone
composition may accompany neuronal conversion of human fibroblasts. Genes encoding
chromatin remodelers important for neurogenesis like CHD5, CHD7 and components of the
BAF chromatin remodeling complex were expressed at higher levels in miNs than in fibroblasts
(Egan et al., 2013; Feng et al., 2013; Lessard et al., 2007) (Figures 2D and S2). Additionally, the
main DNA topoisomerase 2 family member expressed in miNs is TOP2B, which replaces the
non-neuronal TOP2A, a switch that has been observed during normal neuronal differentiation
(Tiwari et al., 2012) (Figures 2D and S2). In sum, dynamic changes and switches within diverse
epigenetic modifiers coincide with neuronal differentiation and appear to be recapitulated in
direct neuronal conversion of fibroblasts by miR-9/9*-124.
Dynamic Regulatory Events During Neuronal Reprogramming
Because transcriptome profiling at day 30 only provided a snapshot of the functional
output of neuronal reprogramming, we explored transcriptome dynamics by profiling
intermediary timepoints (days 3, 6, 10, and 20) by RNA-seq. The Dynamic Regulatory Events
Miner (DREM) (Schulz et al., 2012) reports 13 paths of co-regulated, differentially expressed
genes during the first 20 days of neuronal conversion (Figure 3A). Combining DREM with
predicted TF-gene binding interactions (Ernst et al., 2010) revealed several potential TFs
associated with major regulatory events (bifurcations in each path; Figure 3A). Altogether, major
regulatory events were observed before day 10, suggesting genetic networks are established
within 10 days of miR-9/9*-124 expression. Thereafter, the directionality of gene expression
stays the same but transcript levels markedly change. This transcriptional maturation over time
may explain why the acquisition of functional neuronal characteristics requires 30 days of
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culture. GO analyses of each path revealed enrichment of neuronal terms in the most
upregulated path, whereas down-regulated paths were enriched for cell cycle and extracellular
matrix-related terms (Figure 3B), consistent with results for day 30 transcriptome profiling
(Figure 2C). The transcriptome switch from a fibroblast to a neuronal program was seen as
early as day 10 of miR-9/9*-124 expression (Figure 3C), while genes associated with synaptic
functionality (e.g. HOOK1) are activated at a later time point (day 20, Figure 3C).
Finally, there were no significant changes in ASCL1 or SOX2, TFs that have been used
to reprogram somatic cells into neurons (Niu et al., 2013; Pang et al., 2011). suggesting miR9/9*-124-induced neuronal conversion activates a neuronal program through mechanisms
distinct from those previously reported.
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Figure 3. Time Series Transcriptome Analysis Reveals Early Dynamic Gene Expression
Changes Followed by a Stable Transcriptome Switch
(A) Dynamic Regulatory Event Miner (DREM) analysis reveals multiple paths of co-regulated
genes emerge over time (days).
(B) GO terms enriched in each path (top) and heat maps of genes within the extracellular matrix
and regulation of synaptic transmission terms (bottom). Z-score normalized RPKM.
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(C) Representative genome browser snapshots demonstrating the time-dependent loss of
fibroblast gene expression (top), emergence of pan-neuronal marker gene expression, and
synaptic component expression (bottom).
DNA Methylation Profiling of miNs
After observing numerous changes in DNA methylation machinery we assessed
genome-wide DNA methylation at an early (day 10), intermediate (day 20), and late stage (day
30) of neuronal reprogramming by combining methylated DNA immunoprecipitation sequencing
(MeDIP-seq) and methylation sensitive restriction enzyme sequencing (MRE-seq; Figure 4A)
(Zhang et al., 2013). No significant changes in DNA methylation were detected at day 10
between cells that were exposed to miRNAs and non-treated control (ctrl) cells. In contrast, we
identified 1,540 differentially methylated regions (DMRs) at day 20 (miN day 20 vs. Ctrl day 20)
that overlap with DMRs at day 30 (miN day 30 vs. Ctrl day 30; Figures 4B and 4C). The
difference in DNA methylation at day 30 between treated and control cells was more dramatic
than changes observed at day 20 with most DNA regions undergoing demethylation. Gene
ontology (GO) analysis of Mouse Genome Informatics (MGI) expression using the GREAT
(McLean et al., 2010) tool to characterize the top overlapping DMRs in miNs, enriched only for
neuronal tissue developmental processes (Figure 4D). Interestingly, these differentially
methylated regions undergo changes at TS15 in mouse development (equivalent to mouse
E9/10), which is when miR-9 expression is first detected in developing mouse telencephalon
(Shibata et al., 2008). Two examples of top DMRs within genes important for neuronal
development and function are shown in Figure 4E (Gehrke et al., 2010; Vadhvani et al., 2013).
Nearly 64% of DMRs were located in introns and 28% of DMRs are in intergenic regions (Figure
4F). Comparison of data from day 30 demethylated and methylated DMRs and RNA-seq
revealed 882 differentially expressed genes in total. GO analysis of top demethylated DMRs
associated with upregulated genes (> 2.5 logFC) was enriched for neuronal terms. In contrast,
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top DMRs associated with down-regulated genes (< 2.5 logFC) did not match GO terms
involved in neural development (Figure 4G; data not shown). Furthermore, since miR-9/9*-124
expression quickly induces cell cycle exit, these changes in DNA methylation must necessarily
occur via active processes, such as those catalyzed by TET and TDG enzymes (Kohli and
Zhang, 2013), rather than via failure to remethylate DNA after DNA replication.
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Figure 4. MiR-9/9*-124 Alter DNA Methylation at Neuronal Loci
(A) Schematic of sample collection during miR-9/9*-124-mediated neuronal reprogramming for
DNA methylation studies. Human fibroblasts were transduced with virus expressing miR-9/9*-
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124 or a non-specific (NS) control (Ctrl) virus at day 0. Samples were collected at day 10, day
20, and day 30.
(B) Biclustering analysis of DMRs. Heatmaps based on MeDIP-seq RPKM (left) and MRE-seq
RPKM (right) showing overlapping DMRs at days 20 and day 30.
(C) Quantification of DMRs at multiple q-value cutoffs (q < 5e-2 in red; q < 5e-3 in yellow; q <
5e-4 in purple) across all time points: miN 10 (miN day 10 vs. Ctrl day 10), miN 20 (miN day 20
vs. Ctrl day 20), and miN 30 (miN day 30 vs. Ctrl day 30).
(D) Tissue development enrichment of top overlapping DMRs at day 20 and day 30 show
neuronal tissue terms at TS15 (~E9/10 in mouse development).
(E) WashU Epigenome Browser screenshots of two DMRs: FBXO31 (left) and MIRLET7BHG
(right) loci are shown with MeDIP-seq tracks (red; top), MRE-seq tracks (green; middle), and
DMR positions (purple; bottom).
(F) Genomic distribution of differentially methylated and demethylated regions.
(G) Functional enrichment of top demethylated and upregulated (red; left) or methylated and
downregulated (blue; right) DMRs overlapping at day 20 and day 30 compared with RNA-seq at
day 30.

Chromatin Remodeling in miNs
Extensive expression changes in diverse chromatin remodeling genes during neuronal
reprogramming (Figures 2D and S2) suggest that miR-9/9*-124 may also alter chromatin
accessibility. We therefore performed Assay for Transpose-Accessible Chromatin followed by
high throughput sequencing (ATAC-seq) 10 and 20 days after initiating miR-9/9*-124 induced
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neuronal conversion. A high correlation between replicates confirmed the reproducibility of our
analyses (Figure 5A). We obtained 154,406 total peaks across all samples and identified 59,200
differential peaks (Figure 5B). Of the total peaks detected, 20,712 became more accessible
(open) and 38,882 peaks became inaccessible (closed). Most differential peaks in miNs at day
10 overlapped with the peaks at day 20 and the signal intensity of peaks gradually increased or
decreased during the conversion (Figure 5C), suggesting gradual transition of chromatin
accessibility during reprogramming (Figure 5C). Interestingly, the ratio of open intragenic to
distal intergenic regions increased during miR-9/9*-124-mediated conversion (Figure 5D).
Erasure of Fibroblast Epigenetic Identity and Gain of Neuronal Chromatin Architecture
To gain insight into biological relevance of changes in chromatin accessibility after miR9/9*-124 expression, we performed gene enrichment analysis on genes with differential ATAC
signals around the transcription start site ± 2Kb (TSS). We identified 4,915 genes with gradual
increases and 1,763 genes with gradual decreases in ATAC signals during conversion. Top GO
terms associated with genes with increased ATAC signals are enriched in neuronal terms
(Figure 5E), while closed regions were not (Figure S3A). The number of genes in open regions
associated with neuronal terms gradually increased from day 10 to 20 consistent with our
transcriptional profiling and coinciding with bona fide neuronal commitment of miNs (Figure 5E).
Consistent with this hypothesis, chromatin accessibility for fibroblast marker genes like S100A4,
S100A10, VIM and COL13A1 gradually decreased between 10 and 20 days into neuronal
conversion. Collectively, our ATAC-seq analyses demonstrate miR-9/9*-124-induced chromatin
remodeling events are characterized by concurrent closing of fibroblast-related genomic loci and
opening of neuronal gene loci.
Next, we examined whether miR-9/9*-124-induced chromatin accessibility correlated
with changes in mRNA levels. We compared DEGs (logFC > 2 or < -2 adjusted P-value < 0.01)
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to genes with altered chromatin accessibility around the TSS and identified 501 upregulated and
184 down-regulated genes that coincide with open and close regions, respectively (Figure 5F).
GO enrichment analysis revealed that upregulated genes from open regions associate with
neurogenic terms, while downregulated genes from closed regions are connected with terms
important for fibroblast function (Figure 5G, see S3E for example tracks). This demonstrates the
concordant regulation of transcription and chromatin accessibility during reprogramming.
Interestingly, some opened genomic regions that displayed no changes in gene expression
contained genes that are uniquely expressed in neuronal subtypes, including those enriched in:
dopaminergic neuron markers (TH and SLC6A3), serotonergic neuron markers (FEV, LMX1B
and SLC6A4), GABAergic neuron markers (SLC6A1, SLC32A1, GAD2), striatal medium spiny
neuron marker (PPP1R1B), glutamatergic neuron markers (GLUL and SLC1A6), and
cholinergic or motor neuron markers (MNX1, CHAT, and SLC5A7) (Figure S3G for example
tracks). These results suggest that miR-9/9*-124 poise chromatin to accept additional inputs
from subtype-specifying determinants without activating subtype-specific programs. In all, the
chromatin dynamics observed during miRNA mediated neuronal conversion are consistent with
time-dependent suppression of fibroblast identity concurrent with the opening of neuronal loci
and activation of pan-neuronal gene expression.
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Figure 5. MiR-9/9*-124 Globally Changes Chromatin Accessibility
(A) Two dimensional correlation plot of samples. Pearson’s correlation coefficient: 0.90 for Ctrl
D10 (or FIB); 0.83 for miNs D10 (D10); 0.90 for miNs D20 (D20).
(B) Pie chart showing the proportion of differential peaks and total peaks. Differential peaks
were obtained by combining all significant peaks (Ctrl D10 vs miNs D10, miNs D10 vs miNs
D20).
(C) Heatmaps showing signal intensity in open and close chromatin peaks across all time
points. All open and closed chromatin regions were ranked according to maximum intensity
across all samples.
(D) The genomic distribution of open and closed chromatin regions.
(E) Comparison of GO terms for genes with open chromatin regions at promoters in miNs at day
10 and 20, but closed chromatin regions in fibroblasts.
(F) Heatmaps showing gene expression levels for DEGs positively correlated with ATAC-seq
signal intensity in their promoter regions. Signal intensity is based on normalized counts per
million (CPM) values.
(G) Top GO terms associated with DEGs which correlate with ATAC-seq signal intensity in
promoter regions.
(H) Heatmaps showing signal intensity in the open (accessible) and closed (inaccessible)
chromatin regions that overlapped with histone-marked regions of fibroblasts.
I) Integrated genomics viewer (IGV) screenshots showing two different examples of ATAC-seq
and RNA-seq integration. An example of ATAC-seq and RNA-seq peaks within a pan-neuronal
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gene: MAP2 (left) and an example of ATAC-seq peaks within a subtype-specific locus without
gene expression changes: MNX1 (right).
See also Figures S3 and S4.
MicroRNA-induced Chromatin Remodeling at Heterochromatin Regions in Fibroblasts
To gain a more complete understanding of the epigenetic architecture within opened and
closed chromatin sites we examined the relationship of these regions to pre-existing histone
marks present in fibroblasts. We hypothesized that regions that close during reprogramming
would overlap with the active enhancer/euchromatin marks H3K27ac and H3K4me1 in
fibroblasts. Conversely, regions that open during neuronal reprogramming may overlap with
heterochromatic H3K9me3 and H3K27me3 signatures pre-existing in fibroblasts.
We selected 70,661 regions commonly marked by H3K27ac and H3K4me1 and 5,843
regions commonly marked by H3K9me3 and H3K27me3 in human fibroblasts based on the
Roadmap Epigenome database (Roadmap Epigenomics et al., 2015). We confirmed regions
with altered chromatin accessibility overlapped with these histone marks. Strikingly, we found
that 1,128 ATAC signal peaks present in day 20 miNs that display increased accessibility during
conversion overlapped with regions of fibroblasts marked by H3K9me3/H3K27me3, which were
heterochromatic regions in fibroblasts. Whereas H3K27ac/H3K4me1 marked euchromatic
regions in fibroblasts overlapped with 16,207 peaks that were closed in miNs (Figure 5H). GO
enrichment analysis of genes associated with open chromatin regions in miNs that were marked
by H3K9me3 or H3K27me3 in fibroblasts resulted in neuronal differentiation and functionrelated terms (Figure S3B) In contrast, regions that lose chromatin accessibility in miNs were
enriched with non-neuronal terms (Figure S3D). These results demonstrate the surprisingly
potency of miR-9/9*-124 to open heterochromatin regions needed for neuronal development
and to close enhancer regions that preexist in fibroblasts and are not active in neurons. Our
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results collectively provide an unprecedented demonstration that microRNAs can change
chromatin architecture to promote neuronal and repress fibroblast fates during the direct
conversion of human fibroblasts to neurons.
Chromatin Remodeling is Required for Direct Conversion
To determine if chromatin changes were necessary for cell fate conversion we knocked
down the expression BRG1, a core component of BAF chromatin remodeling complex whose
reduced function has been shown to collapse the overall chromatin architecture (Kadoch et al.,
2017). After 20 days of neuronal conversion, loss of BRG1 markedly decreased the amount of
MAP2 positive cells when compared to a control shRNA (Figure S4A). ATAC-seq revealed
regions which failed to open in response to miR-9/9*-124 in the absence of BRG1 (Figure S4A).
These regions were associated with neuronal GO terms in contrast to the fibroblast-related GO
terms associated with regions that failed to close (Figure S4D). These data demonstrate the
requirement of chromatin remodeling in cell fate conversion. Collectively, our transcriptome and
ATAC-seq results provide mechanistic insight into the possibility of deriving additional clinically
relevant neuronal subtypes through miRNA-mediated conversion in addition to cortical and
striatal medium spiny neurons (Victor et al., 2014; Yoo et al., 2011).
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Figure S1, Related to Figure 1
MiRNA-Mediated Conversion into Neuronal Fate is Stable
(A) Detailed schematic of miR-9/9*-124 direct conversion protocol.
(B) Combined plot of the current (I) - voltage (V) relationship for every neuron recorded.
(C) Tabulated values of miN resting membrane potentials.
(D) Gap-free recording of miN resting membrane potential.
(E) Tabulated values of miN capacitance values
(F) MiR-9/9*-124 was ectopically expressed under a doxycycline (DOX) inducible promoter in
22 year old human fibroblasts for 30 days then DOX was removed from the media and cells were
cultured for an additional 30 days. Stable adoption of the neuronal fate was assayed by
immunostaining for the pan-neuronal markers MAP2, NeuN, TUBB3 and NCAM. To assay if
cells remained post-mitotic cells were stained with the proliferative marker ki-67. Scale bar =
20µm.
All data are represented as mean ± SEM.
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Figure S2, Related to Figure 2
Widespread Expression Changes in Epigenetic Modifiers During Reprogramming
Heatmaps show expression changes observed between miNs and fibroblasts within a subset of
proteins that recognize or modify distinct parts of the epigenome
43
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Figure S3, Related to Figure 5
Pre-existing Heterochromatic Neuronal Loci Open in Response to miR-9/9*-124
Expression.
(A) Top GO terms associated term with promoter regions that close during reprogramming from
fibroblasts to miNs.
(B) Closed regions in fibroblasts marked by H3K9me3 that open during neuronal reprogramming
are enriched for neuronal GO terms.
(C) Closed regions in fibroblasts marked by H3K27me3 that open during reprogramming are
also enriched for neuronal GO terms.
(D) Pre-existing distal H3K27ac and H3K4me1 marks within fibroblasts that close during
neuronal reprogramming show GO terms related to general biological processes.
(E) Genome browser snapshots demonstrating closing and loss of fibroblast gene expression
(ECM1, MFAP5, and VIM).
(F) Genome browser snapshots demonstrating neither opening or activation of gain of progenitor
genes (SOX2, OLIG2 and ASCL1).
(G) Genome browser snapshots demonstrating neuronal subtype gene loci that open, but do not
show gene expression changes (GAD2 and GABRA2, GABAergic markers; TH, dopaminergic
neuron marker).
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Figure S4, Related to Figure 5
Loss of BRG1 Prevents Neuronal Fate Acquisition
(A) Adult human fibroblasts ectopically expressing miR-9/9*-124 and shBRG1 or shEGFP
control for 20 days immunostained for the pan-neuronal marker MAP2 and fibroblast marker
FSP1. Scale bars = 20µm.
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(B) Quantification of (A) MAP2 and FSP1 positive cells over total number of cells (DAPI). For
MAP2, only cells with processes at least three times the length of the soma were counted. Data
are represented as mean ± SEM. shBRG1 n = 155 cells, shEGFP, n = 173 cells,
(C) Heatmaps showing signal intensity in open and close chromatin peaks in shBRG1 and
shEGFP. All open and closed chromatin regions were ranked according to maximum intensity
across all samples.
(D) The genomic distribution of open and closed chromatin regions.
(E) GO terms showing biological function of closed (lost in shBRG1, red) and open (retained in
shBRG1, blue) regions.
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Materials and Methods
Cell Culture
Adult and neonatal human fibroblasts were obtained from commercial sources and
maintained in fibroblast media comprised of Dulbecco’s Modified Eagle Medium (Invitrogen)
supplemented with 15% fetal bovine serum (Life Technologies), 0.01% β- mercaptoethanol (Life
Technologies), 1% non-essential amino acids, 1% sodium pyruvate, 1% GlutaMAX, 1% 1M
HEPES buffer solution, and 1% penicillin/streptomycin solution (all from Invitrogen). Cells
were never passaged more than 15 times.
Plasmid construction and virus production.
Complementary cDNA was generated from adult human spinal cord (Clontech) from
which individual motor neuron transcription factors (Figure S5A) were subcloned into the N174
and N106 lentiviral vectors using standard techniques. Lentivirus was produced in 293le cells
plated in 10cm dishes (6.5 x 10^6 cells per dish) via polyethylineimine (48 µL of 2 mg/mL,
Polysciences) assisted transfection of 3rd generation packaging vectors (1.5 µg pMD2.G and 4.5
µg psPAX2), and 6 µg of lentiviral backbone plasmid (e.g. pT-BCL-9/9*-124) 16 hours after
initial plating. Media was changed the next day. After 2 days, media was harvested, filtered
through a 0.45 µm polyethersulfone (PES) syringe filter and then concentrated by centrifugation
at 70,000xG for 2 hours at 4°C. Virus collected from a single 10 cm dish was resuspended in 1
mL of sterile PBS then aliquoted and stored at -80°C. Before each transduction, virus aliquots
were spun at 5,000xG for 5 minutes at 4°C to remove debris. Control vector expressing nonspecific (NS) miRNA and BCL-XL was generated previously (Victor et al., 2014).
Direct Conversion
To initiate direct conversion, 1.8x10^6 cells were seeded onto Costar 6 well cell culture
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vessels (Corning; 300,000 cells/well). The following day, each plate was transduced with the
following reprogramming cocktail: 750 uL of concentrated lentivirus containing the reverse
tetracycline-controlled transactivator (rtTA; Addgene, 66810) and 500 µL of virus containing
pT-BCL-9/9*-124 or pT-BCL-9/9*-124 plus 500 µl of each individual TF driven by the EF1α
promoter in the presence of polybrene (8 µg/mL ; Sigma-Aldrich) all diluted up to 18 mL (3 mL
per well) then spinfected at 37°C for 30 minutes at 1,000xG using a swinging bucket rotor. The
following day media was changed to fresh fibroblast media (2 mL per well) supplemented with
doxycycline (Dox; Sigma Aldrich, 1 µg/mL). After 2 days, fresh fibroblast media was changed
and supplemented with Dox and antibiotics for respective vectors (Puromycin, 3 µg/ml;
Blasticidin 5 µg/ml; Geneticin, 400 ug/mL; all from Invitrogen). Five days post-transduction
cells were replated on to poly-ornithine/laminin/fibrobnectin (PLF) coated glass coverslips.
Before PLF coating, glass coverslips were acid treated according to (Richner et al., 2015). To
transfer cells, for each well of a 6 well plate, cells were first washed 2x with 1 mL sterile PBS.
Then 320 µL of 0.25% Trypsin (Gibco) was added to each well then placed in an incubator. Cells
were monitored every 2 minutes, as soon as cells began to detach (no more than 6 minutes) 1 ml
of MEF media supplemented with 1 µg/mL Dox was added to each well. One by one, each well
was gently triturated three times to remove remaining attached cells then transferred to a sterile
1.5 mL Eppendorf tube. Cells were then spun at 200xG for 5 minutes at 37°C. The supernatant
was aspirated and cells were gently resuspended in 300 µL MEF media supplemented with Dox.
Cells were then drop-plated onto either 18 mm (150 µL per/c.s.; placed in 12 well plate) or
12mm (60 µL per c.s.; placed in 24 well plate) coverslips. Cells were left to settle for 15 minutes
in an incubator then each well was flooded with MEF media supplemented with 1 µg/mL Dox.
The following day media was then changed to Neuronal Media (Sciencell) supplemented with
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Dox, valproic acid (1 mM; EMD Millipore) dibutyryl cAMP (200 µM; Sigma-Aldrich), BDNF,
NT-3, CNTF, GDNF (all 10 ng/ml, Peprotech), and Retinoic Acid (1 uM; Sigma-Aldrich) and
antibiotics for each vector. Dox was replenished every two days and half the media was changed
every 4 days. Drug selection was halted 14 days into conversion. A diagram of the
reprogramming protocol is available in Figure S1.
For time-course studies, the above reprogramming protocol was utilized with the
following exception. In 3 day intervals starting on reprogramming day 9, a full media change
excluding DOX was used to effectively remove DOX from the well at each timepoint.
For DNA methylation profiling, 1.8x10^6 human neonatal fibroblasts were seeded onto
10 cm plates (Corning). To achieve the cell number required for meDIP and MRE-seq human
neonatal fibroblasts were utilized as adult fibroblasts were unable to expand to sufficient
quantities. The following day, each plate was transduced with 10 ml of un-concentrated
lentivirus containing media with a doxycycline inducible miR-9/9*-124 vector (Victor et al.,
2014) and polybrene (8 µg/mL ; Sigma-Aldrich). The following day media was changed
to fresh fibroblast media (2 mL per well) supplemented with Dox. After 2 days, fresh fibroblast
media was changed and supplemented with Dox and antibiotics for respective vectors (see Table
1). Seven days post-transduction, cells were first washed 2x with 3 mL sterile PBS. Then 1 ml of
0.25% Trypsin (Gibco) was added to each plate then placed in a 37oC tissue culture incubator.
Cells were monitored every 2 minutes and as soon as cells began to detach (no more than 6
minutes), 4 ml of MEF media supplemented with 1 µg/mL Dox was added to each plate. Cells
were transferred to Primaria modified 10 cm plates (Corning) and 5 ml fresh fibroblast media
supplemented with 1 µg/mL Dox was added to a final volume of 10 ml. The following day media
was changed to Neuronal Media (Sciencell) supplemented with Dox, valproic acid (1 mM; EMD
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Millipore) dibutyryl cAMP (200 µM; Sigma-Aldrich), BDNF, and NT-3 (all 10 ng/ml,
Peprotech), Retinoic Acid (1 uM; Sigma-Aldrich), and 4% FBS. Dox was replenished every two
days and half the media was changed every 4 days.
Immunocytochemistry and cell counting
Cells were fixed using 4% formaldehyde for 18 minutes at room temperature (RT) then
blocked and permeabilized for one hour at room temperature in PBS containing 0.3% TritonX100, 5% bovine serum albumin (Sigma-Aldrich), and 2% of either goat or donkey serum
(Sigma-Aldrich). Primary antibodies were incubated overnight at 4°C in blocking buffer. Cells
were then washed 3x and incubated with secondary antibodies conjugated to either Alexa-488, 594 or -647, for one hour at room temperature. a-Bungarotoxin was incubated with secondary
antibodies at a concentration of 1:200. Images were obtained on a Leica SP-2 Confocal
Microscope. Quantifications were performed on at least 6 random fields of view in duplicate
experiments.
Electrophysiology
Whole-cell patch-clamp recordings were performed 35-40 days post-transduction. Data
was acquired using pCLAMP 10 software with multiclamp 700B amplifier and Digidata 1550
digitizer (Molecular Devices). Electrode pipettes were pulled from borosilicate glass (World
Precision Instruments) and typically ranged between 5–8 MΩ resistance. Intrinsic neuronal
properties were studied using the following solutions (in mM): Extracellular: 140 NaCl, 3 KCl,
10 Glucose, 10 HEPES, 2 CaCl2and 1 MgCl2 (pH adjusted to 7.25 with NaOH). Intracellular:
130 K- Gluconate, 4 NaCl, 2 MgCl2, 1 EGTA, 10 HEPES, 2 Na-ATP, 0.3 Na-GTP, 5 Creatine
phosphate (pH adjusted to 7.5 with KOH). Membrane potentials were typically kept at -65 mV.
In voltage-clamp mode, currents were recorded with voltage steps ranging from -20 mV to +90
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mV. In current-clamp mode, action potentials were elicited by injection of step currents that
modulated membrane potential from -10 mV to +35 mV. Data was collected in Clampex and
initially analyzed in Clampfit (Molecular Devices). Further analysis was done in GraphPad
Prism 7 (GraphPad Software). Liquid junction potential was calculated to be 15.0 mV and
corrected in calculating resting membrane potential according to previously published methods
(Barry, 1994).
RNA-Seq library preparation and sequencing
Day 30 miNs and starting human adult fibroblasts (22 yr old) were extracted by RNeasy
plus micro kit (Qiagen). The RNA samples with > 9.5 of RIN based on a 2100 Bioanalyzer were
used for RNA-Seq library preparation. Library preparation and sequencing were performed by
Genome Technology Access Center in Washington University School in St. Louis. Briefly
mRNA was isolated by using SMARTer Ultra Low RNA Kit for Illumina sequencing
(Clontech). All cDNA libraries, based on two biological replicates for each condition, were
sequenced on Illumina Hi-Seq 2500 with single-end 50 bp read length.
For RNA-seq time series data in Figure 3, total RNA was extracted from starting human
adult fibroblasts (22 yr old) and day 3, 6, 10, and 20 miNs by RNeasy plus micro kit (Qiagen).
The RNA samples with > 9.5 of RIN based on a 2100 Bioanalyzer were used for RNA-Seq
library preparation. Total RNA was processed for library construction by Cofactor Genomics
(http://cofactorgenomics.com, St. Louis, MO) according to the following procedure: Briefly,
total RNA was reverse-transcribed using an Oligo(dT) primer, and limited cDNA amplification
was performed using the SMARTer® Ultra® Low Input RNA Kit for Sequencing – v4 (Takara
Bio USA, Inc., Mountain View, CA ). The resulting full-length cDNA was fragmented and
tagged, followed by limited PCR enrichment to generate the final cDNA sequencing library
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(Nextera® XT DNA Library Prep, Illumina, San Diego, CA). Libraries were sequenced as
single-end 75 base pair reads on an Illumina NextSeq500 following the manufacturer's
instructions by Cofactor Genomics.
RNA-Seq data analysis
More than 35 million reads of each RNA-seq data were aligned to human genome
assembly GRCh 37. For differential expression analysis, edgeR and limma were used. Genes
with low read counts, regarded as genes not expressed at a biologically meaningful level were
filtered out before read normalization. The cut-off for low read count was counts per million
(CPM) <1 in at least any two samples across the experiment. Reads for each sample were
normalized by the edgeR method of trimmed mean of M-values (TMM). The quantitative
difference of read counts between miNs and starting fibroblast samples were evaluated by
carrying out limma and graphically represented by Glimma. Gene enrichment analysis for
differentially expressed genes was performed using Metascape Gene Annotation and Analysis
Resource tool.
For RNA-seq time series data in Figure 3, quality control, alignment, clustering,
normalization, and expression comparison were performed by Cofactor Genomics
(http://cofactorgenomics.com, Saint Louis, Missouri, USA). Raw sequence data in FASTQ
format were assessed for quality (FastQC,
http://www.bioinformatics.babraham.ac.uk/projects/fastqc/) and ribosomal RNA content
(sortmeRNA, http://bioinfo.lifl.fr/RNA/sortmerna/). NovoAlign (Novocraft,
http://novocraft.com) was used to align reads to a set of transcript sequences. NovoAlign
parameters were set to allow multiple alignments to the transcriptome set to allow for isoforms.
Alignments to the genome were performed using STAR (https://github.com/alexdobin/STAR).

53

Only unique alignments to the genome were allowed. The genome alignment loci from all
samples were combined and clustered to generate genomic loci (“patches”) with contiguous read
coverage. Patches overlapping reference genome annotation loci were labelled as such. For each
transcript or patch, the RPKM expression value was calculated for each sample. These RPKM
values are the basis for expression comparison and statistics generation. For each replicate group,
the mean and coefficient of variation for each transcript or patch were calculated across the
expression values for the samples in that group. These means were considered to be the
expression values for the replicate group. P-values were calculated between the means of each
pair of replicate groups using a Welch’s t-test corrected for FDR by the method of BenjaminiHochberg
DREM Analysis
The Dynamic Regulatory Events Miner (DREM) and cDREM were used to integrate time
series gene expression data with predicted TF-gene binding interactions (top 100 genes per
PWM from Ernst et al., 2010 to identify patterns of temporal gene expression patterns and the
associated regulators. The log fold change of 7310 DE genes (fold-change > 10; q-value < 0.1)
was used to generate all paths in Figure 3.
Methylated DNA immunoprecipitation sequencing
MeDIP-seq was performed as in Maunakea et al. (Maunakea et al., 2010). Five
micrograms of genomic DNA was sonicated to a fragment size of ~100-400 bp using the
Bioruptor sonicator (Diagenode). End-repair, addition of 3’-A bases and PE adapter ligation with
2 µg of sonicated DNA was performed according to the Illumina Genomic DNA Sample Prep
Kit protocol. Adapter-ligated DNA fragments were size selected to 166-366 bp and purified by
gel electrophoresis. DNA was heat denatured and then immunoprecipitated with 5-
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methylcytidine antibody (Eurogentec; 1 µg of antibody per 1 µg of DNA) in 500 µl of
immunoprecipitation buffer (10 µM sodium phosphate, pH 7.0, 140 mM sodium chloride and
0.05% Triton X-100) overnight at 4 °C. Antibody/DNA complexes were isolated by addition of
1 µl of rabbit anti-mouse IgG secondary antibody (2.4 mg ml-1, Jackson Immunoresearch) and
100 µl protein A/G agarose beads (Pierce Biotechnology) for 2 h at 4 °C. Beads were washed
nine times with immunoprecipitation buffer and then DNA was eluted in TE buffer with 0.25%
SDS and 0.25 mg ml-1 of proteinase K for 2 h at 50 °C. DNA was then purified with the Qiagen
QIAquick kit and eluted in 30 µl EB buffer. Ten microliters of DNA was used for a PCRenrichment reaction with PCR PE Primers 1.0 and 2.0. PCR products were size selected (220420 bp) and purified by gel electrophoresis. Methylated DNA enrichment was confirmed by PCR
on known methylated (SNRPN and MAGEA1 promoters) and unmethylated (a CpG-less
sequence on chromosome 15 and glyceraldehyde 3-phosphate dehydrogenase promoter)
sequences. DNA libraries were checked for quality by Nanodrop (Thermo Scientific) and
Agilent DNA Bioanalyzer (Agilent). Reads were aligned to hg19 using BWA and pre-processed
using methylQA (an unpublished C program; available at http://methylqa.sourceforge.net/).
Detailed library construction protocols for MRE-seq and MeDIP-seq are publically available at
the NIH Roadmap Epigenomics project website
(http://www.roadmapepigenomics.org/protocols/type/experimental/.
Methylation-sensitive restriction enzyme sequencing
MRE-seq was performed as in Maunakea et al. (Maunakea et al., 2010), with
modifications as detailed below. Five parallel restriction enzyme digestions (HpaII, Bsh1236I,
SsiI(AciI) and Hin6I (Fermentas), and HpyCH4IV (NEB)) were performed, each using 1 µg of
DNA per digest for each of the samples. Five units of enzyme were initially incubated with DNA
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for 3 h and then an additional five units of enzyme were added to the digestion for a total of 6 h
of digestion time. DNA was purified by phenol/chloroform/isoamyl alcohol extraction, followed
by chloroform extraction using phase lock gels. Digested DNA from the different reactions was
combined and precipitated with one-tenth volume of 3 M sodium acetate (pH 5.2) and 2.5
volumes of ethanol. The purified DNA was size selected and purified (50-300 bp) by gel
electrophoresis and Qiagen MinElute extraction. Library construction was performed as per the
Illumina Genomic DNA Sample Prep Kit protocol with the following modifications. During the
end-repair reaction, T4 DNA polymerase and T4 PNK were excluded and 1 µl of 1:5 diluted
Klenow DNA polymerase was used. For the adapter ligation reaction, 1 µl of 1:10 diluted PE
adapter oligo mix was used. Ten microliters from the 30 µl of purified adapter ligated DNA was
used for the PCR enrichment reaction with PCR PE Primers 1.0 and 2.0. PCR products were size
selected and purified (170-420 bp) by gel electrophoresis and Qiagen QIAquick extraction. DNA
libraries were checked for quality by Nanodrop (Thermo Scientific) and Agilent DNA
Bioanalyzer (Agilent). Reads were aligned to hg19 using BWA and pre-processed using
methylQA. MRE reads were normalized to account for differing enzyme efficiencies and
methylation values were determined by counting reads with CpGs at fragment ends (Maunakea
et al., 2010).
Differential DNA-methylated region analysis
The M&M statistical model (Zhang et al., 2013), which integrates MeDIP-seq and MREseq data to identify differentially methylated regions between two samples was implemented
with a window size of 500 bp and a q-value (false discovery rate (FDR)-corrected P-value)
cutoff of 5e-2. This cutoff was determined from Figure 3C, where only 1 DMR was detected at
day 10 (miN day 10 vs. Ctrl day 10). For Figure 3B, only regions that were considered DMRs (q-
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value < 1e-5) at both day 20 (miN day 20 vs. Ctrl day 20) and day 30 (miN day 30 vs. Ctrl day
30) are displayed.
GO enrichment analyses
DNA methylation GO analyses of MGI (Mouse Genome Informatics) expression (Smith
et al., 2014) presented in Figure 3D were performed using the GREAT package (McLean et al.,
2010). Gene regulatory domains were defined by default as the regions spanning 5 kb upstream
and 1 kb downstream of the TSS (regardless of other nearby genes). Gene regulatory domains
were extended in both directions to the nearest gene’s basal domain, but no more than a
maximum extension in one direction. The top 100 most significant overlapping DMRs from day
20 (miN day 20 vs. Ctrl day 20) and day 30 (miN day 30 vs. Ctrl day 30) were used as input. For
Figure 3G, GO analyses were performed using Metascape (Tripathi et al., 2015) with a minimum
enrichment of 1.5, a minimum overlap of 3, and a p-value cutoff of 0.01 using all demethylated
or methylated DMRs at day 30 (miN day 30 vs. Ctrl day 30) that were either up- or downregulated, respectively, by RNA-seq at day 35 using a cutoff of 2.5 logFC.
Genomic features
DMRs from day 30 (miN day 30 vs. Ctrl day 30) were segregated into exons, introns,
intergenic regions, 3’ UTRs, 5’ UTRs, non-coding regions, promoter-TSSs, and TTSs by using
the annotatePeaks program provided by HOMER (Heinz et al., 2010).
ATAC-sequencing library preparation and data processing
ATAC-seq was performed as previously described (Buenrostro et al., 2013). Briefly,
50,000 cells were collected for ATAC-seq library preparation at Ctrl day 10, miNs day 10, miNs
day 20, shBRG1 Day20 and shEGFP day 20. Transposition reaction was carried out with
Nextera Tn5 Transposase for 30 min at 37 °C. Library fragments were amplified for optimal
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amplification condition. Final libraries were purified using AMPure XP beads (Ampure) and
sequenced with 50 bp paired-end reads on Illumina HiSeq 2500.
More than 50 millions of ATAC-seq reads were trimmed for Nextera adapter sequences
using TrimGalore and aligned to hg19 human genome assembly using bowtie2 with parameters -very-sensitive --maxins 2000 --no-discordant –-no-mixed. Duplicate reads were discarded with
Picard and uniquely mapped reads were used for downstream analysis. Peaks were called using
Homer with parameters findPeaks -region -size 150 -minDist 300. Peaks called from all the
samples were combined together and raw reads mapped on the combined peaks were counted
using HTSeq count. Differential peaks between any two different samples were identified using
edgeR with a cut-off: a fold-change threshold of 1.5 and FDR < 0.01. Differential peaks were
regarded as peaks that are gained or lost at each time point.
Gained peaks at miNs D10 and D20 were combined together and defined as open
chromatin regions. Conversely, all lost peaks at miNs D10 and D20 were defined as close
chromatin regions. The genomic features in the differential open and close chromatin regions
were distributed by the CEAS software (Shin et al., 2009). We annotated Ref-seq genes that are
most nearest located from differential peaks with Homer annotatePeaks command. Based on
those genomic distribution and peak annotation, we defined the promotor regions (-/+ 2Kb of
TSS) and distal regions (all peak positions except the promoter regions). GO enrichment analysis
were performed by Metascape or the Gene Ontology. All heatmaps were made based on
normalized signal intensity values (i.e. log2CPM) of each sample on relevant specific regions.
All histone mark ChIP-seq data were obtained from Roadmap Epigenome database of human
fibroblasts (Roadmap Epigenomics et al., 2015). To identify histone mark-occupied chromatin
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accessibility during reprogramming, we compared each histone ChIP-seq data with open and
close chromatin regions based on ATAC-seq. We confirmed that most open and close chromatin
peaks overlapped with histone mark-ChIP peaks were found in regions outside of promoter
regions (+/- 2Kb of TSS). Open and close chromatin regions excluding the promoter regions
were then used to compare with histone ChIP-seq data and perform further GO enrichment
analysis.
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Abstract
Motor neurons provide the electrical bridge between the brain and musculature enabling
vertebrates to interact with their environment. The inherent complexity in motor behaviors
requires a robust developmental program to ensure proper specification, differentiation, and
connection of motor neurons. A large amount of progress has been made in the study of each of
these aspects of motor neuron biology. This work has been inspired by the disorders that arise
when this intricate system is perturbed by disease or injury. Most well known of the motor
neuron disorders are Amyotrophic Lateral Sclerosis (ALS), Spinal Muscular Atrophy (SMA) and
Spinal Cord Injuries (SCI). Despite our increased understanding of motor neuron biology, a cure
for any of these debilitating diseases has not been found. One of the greatest hurdles in studying
neurodegenerative diseases is access the affected cell types. The location and absolute necessity
of neurons within the human body prohibits their extraction for further studies. Furthermore,
post-mortem samples cannot be expanded in culture since neurons are post-mitotic, thus
preventing the accumulation of cell numbers needed for proper experimentation. In the same
vein, neurons lost in these diseases cannot be replaced by the host as there is little adult
neurogenesis (Ming and Song, 2011). If it were possible to generate the neurons affected by
these diseases in vitro, a valuable resource would open up both for neurodegenerative disease
modeling and prospective regenerative therapies. Our lab has previously shown that the ectopic
expression of the brain enriched miRNAs, miR-9/9* and miR-124 (miR-9/9*-124) is sufficient
to convert human fibroblasts into a heterogeneous population of both excitatory and inhibitory
neurons (Yoo et al., 2011). Importantly, this method robustly converts cells originating from
adult humans, a cell type historically difficult to reprogram efficiently (Caiazzo et al., 2011; Ring
et al., 2012; Vierbuchen et al., 2010).
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With the observation that neurodegenerative diseases often affect specific cell types we
have sought to guide this conversion into distinct neuronal subtypes. We have found that ectopic
co-expression of transcription factors enriched in specific regions of the brain and miR-9/9*-124,
reprograms fibroblasts into the neuronal subtype that resides within the region of interest (Victor
et al., 2014). For example, the introduction of transcription factors enriched in the striatum to the
miRNA-mediated reprogramming process guides conversion into striatal medium spiny neurons
(MSNs), the principle cell-type affected in Huntington’s disease. The ability of miR-9/9*-124 to
open loci important in the acquisition and maintenance of multiple neuronal subtypes, including
but not limited motor neuron loci, suggests that motor neurons could be derived through the
addition of motor neurons transcription factors to miR-9/9*-124. In pursuit of this hypothesis I
screened a pool of developmentally informed motor neurons transcription factors in the
background of ectopic miR-9/9*-124 expression and assayed for the acquisition of motor neuron
identity. I identified two transcription factors, ISL1 and LHX3, that when co-expressed with
miR-9/9*-124 were sufficient to directly convert adult human fibroblasts into functional motor
neurons. Further, these motor neurons share significant genetic networks with their in vivo
mouse counterparts, suggesting that this reprogramming modality is capable of generating bona
fide motor neurons.
Main Text
Instructing the miRNA-induced Neurogenic State to a Motor Neuron Fate
The deposition and removal of nucleosomes along regulatory elements within DNA
inhibits or enables the binding of TFs, simultaneously facilitating and reinforcing cell-type
specific gene expression programs (Jiang and Pugh, 2009). In our previous analyses we noted
chromatin regions in miNs with enhanced accessibility were proximal to MNX1 and choline
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acetyl transferase CHAT, two of the hallmark genes expressed by motor neurons (Fonnum,
1973; Tanabe et al., 1998) (Figure 5I). Neither MNX1 nor CHAT mRNA levels were elevated in
day 30 miNs after miR-9/9*-124 directed neuronal conversion, but we hypothesized the open
chromatin would facilitate expression of these genes in response to motor neuron-specific TFs.
To test this hypothesis we expressed a panel of TFs known to promote motor neuron identity
(Figure S5A) in combination with ectopic miR-9/9*-124 expression, and assayed for MAP2 and
MNX1 expression by immunostaining (data not shown). While all combinations resulted in
MAP2 positive cells, only ISL1 and LHX3 robustly led to the generation of MNX1-positive cells.
Co-expressing LHX3 and ISL1 with miR-9/9*-124 in adult human fibroblasts from 22-, 42-, 56and 68-year old donors resulted in MAP2, TUBB3 and NCAM-positive cells with complex
neuronal morphologies (Figures 6A and 6B). Approximately 80% of cells positive for DAPI
staining were positive for TUBB3, MAP2 and NCAM expression (Figure 6C). The majority of
converted cells displayed nuclear staining of MNX1 (~85% of TUBB3 positive cells in each line,
Figures 6D and 6E). Similarly, cytoplasmic CHAT protein and SMI-32 (a neurofilament protein
found in motor neurons) were detected in ~80% of TUBB3 positive cells within each age group
(Figure 6D and 6E).
Interestingly, ISL1 and LHX3 alone were not sufficient to induce neuronal conversion
when co-expressed with a non-specific miRNA (miR-NS) (Figure S5B), supporting the notion
that miR-9/9*-124 is necessary for the subtype-specifying activities of ISL1 and LHX3. Motor
neuron conversion induced by miR-9/9*-124 plus ISL1 and LHX3 was stable, displaying
neuronal morphologies, cell cycle exit, and motor neuron marker expression for 30 days after
doxycycline removal (Figure 6F).

63

64

Figure 6. MiRNA-Induced Neuronal Competence Enables Motor Neuron Transcription
Factors, ISL1 and LHX3, to Determine Motor Neuron Identity.
(A) Schematic of neuronal induction paradigm using miR-9/9*-124 plus ISL1 and LHX3.
(B) Representative immunohistochemistry for pan-neuronal markers in neurons generated from
fibroblasts through 35 days of ectopic miR-9/9*-124, ISL1, and LHX3 co-expression. Fibroblasts
were isolated from a 22 year old female donor. Scale bars = 20µm.
(C) Quantification of 4 independent primary human fibroblast lines from both male and female
donors stained with TUBB3, MAP2 and NCAM. Percentages represent total number of positive
cells over all cells (DAPI) and are represented as mean ± SEM. Cells analyzed: 22 yr old
N=TUBB3 325, MAP2 219, NCAM 275; 42 yr old N=TUBB3 304, MAP2 236, NCAM 129; 56 yr
old N=TUBB3 275, MAP2 279, NCAM 213; 68 yr old N=TUBB3 282, MAP2 234, NCAM 190.
(D) Expression and correct localization of motor neuron markers in neurons converted by miR9/9*-124 and ISL1/LHX3 as demonstrated by immunohistochemistry. MNX1, (top), CHAT
(middle) and SMI-32 (bottom). Scale bars = 20µm.
(E) Quantification of (D) represents the total percentage of MNX1, CHAT and SMI-32-positive
cells over TUBB3-positive cells. Data are represented as mean ± SEM. Cells analyzed: 22 yr
old N=MNX1 256, CHAT 256, SMI-32 113; 42 yr old N= MNX1 151, CHAT 151, SMI-32 283; 56
yr old N= MNX1 207, CHAT 207, SMI-32 174; 68 yr old N= MNX1 151, CHAT 151, SMI-32 96.
(F) After 30 days of neuronal conversion by ectopic miR-9/9*-124 expression, doxycycline was
removed and cells were cultured for an additional 30 days. Immunocytochemistry showing
motor neurons produced by miR-9/9*-124 plus ISL1 and LHX3 (Moto-miNs) remain Ki-67
negative (2nd panel), retain expression and localization of the neuronal proteins TUBB3, NEUN,
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and MAP2 (2nd and 3rd panel), and express the motor neuron proteins MNX1 and CHAT (4th and
5th panel). Scale bars = 20µm.
See also Figure S5.
Electrophysiological properties of Moto-miNs
Motor neurons produced from fibroblasts by co-expression of miR-9/9*-124, ISL1 and
LHX3 (Moto-miNs) demonstrated robust inward and outward currents in response to
depolarizing steps (Figure 7A) and displayed action potential trains through the injection of stepwise depolarizations (Figures 7B and S5C). The visualization of single traces recorded at
individual current steps revealed the characteristic hyperpolarization following each action
potential seen in mature neurons (Figure 7C). To assess the percentage of functionally mature
Moto-miNs, we patched 45 randomly chosen Moto-miNs from 22-year-old and 68-year-old
donors. All Moto-miNs fired APs. Most cells fired multiple APs (80% n=20 and 74% n=25) while
single APs were observed in ~20-25% of the patched cells (Figure 7D). Gap-free recordings in
current clamp mode revealed cells capable of firing spontaneous action potentials (Figure 7E),
demonstrating the excitability of these cells. Similar I-V curve relationships were observed
between donors and firing patterns (Figure 7F). Peak inward currents were substantially higher
than those observed in miNs (Figure S6A). Lastly, resting membrane potentials in all Moto-miNs
tested were hyperpolarized (Figure 7G; 22 yr old, -67.2 mV ± 3.3 mV; 68 yr old, -72.8 mV ± 2.0
mV, S.E.M.). Coupled with the increased proportion of cells that fire multiple APs these data
suggest that the addition of ISL1 and LHX3 to miR-9/9*-124 produced more mature neurons
than exposure to miR-9/9*-124 alone.
The ability of motor neurons to control voluntary muscle movement stems from their
ability to form neuromuscular junctions (NMJs), unique synapses formed between motor
neurons and muscle cells. The formation of NMJs was visualized through the co-localization of
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EGFP-labeled Moto-miNs, Alexa-fluor-594 Bungarotoxin (BTX, a toxin that binds to the nicotinic
acetylcholine receptor (AChR) of NMJs), and myosin heavy chain. BTX puncta were not
observed in the absence of Moto-miNs (Figure 7H, left inset). In contrast, Moto-miNs were able
to induce characteristic BTX-clustering in close apposition with EGFP labeled neurons and
myotubes (Figure 7H) indicating the formation of putative NMJs.
Transcriptional Profiling of Moto-miNs
To fully characterize the acquisition of a motor neuron fate and assess the contribution
of ISL1 and LHX3, we profiled the transcriptome of 22-yr-old starting fibroblasts, miNs and
Moto-miNs by microarray. We again observed the loss of fibroblast gene expression (for
example, S100A4, VIM and COL13A1), and the gain of a pan-neuronal identity (for example,
MAP2, NEFL, SNAP25 and SCN1A) 35 days after the expression of miR-9/9*-124 (Figure 7I).
Expression of motor neuron-specific genes was not significantly different between starting
fibroblasts and miNs. While the addition of ISL1 and LHX3 to miR-9/9*-124 did not significantly
change the expression of pan-neuronal genes when compared to miNs (Figure 7J), ISL1 and
LHX3 selectively activated key motor neuron genes including MNX1, CHAT, VACHT, LMO1 and
LMO4 (Figure 7J). We further validated the loss of fibroblast identity and gain of motor-neuron
identity in Moto-miNs derived from 42-, 56- and 68-year-old donors by qRT-PCR using RNA
from human spinal cord as a positive control (Figure 7K). In addition, we observed dramatic
upregulation of miR-218, a recently identified motor neuron-specific microRNA (Amin et al.,
2015; Thiebes et al., 2015) in Moto-miNs (Figure 7L).
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Figure 7. Functional Properties and Gene Expression Profile of Moto-miNs
(A) Representative traces of inward sodium and outward potassium whole-cell currents.
(B) Repetitive AP waveforms in response to 500 ms current injections recorded from Moto-miNs
converted in monoculture.
(C) Representative waveforms of a single Moto-miN at increasing current injections.
(D) Summary of firing patterns observed in Moto-miNs converted from both old and young
donors. 68 yr old 80% multiple (N=20), 22 yr old 74% multiple (N=25).
(E) Spontaneous firing activity was observed in a small percentage of Moto-miNs (3/20).
(F) Combined plot of the current (I) - voltage (V) relationship for every Moto-miN recorded. Data
are represented as mean ± SEM.
(G) Moto-miNs converted from both young and old donors are hyperpolarized, demonstrating
mean resting membrane potentials of -67.2mV and -72.8mV, respectively. Data are represented
as mean ± SEM.
(H) Staining of Moto-miNs cultured with differentiated human myotubes. Moto-miNs were
labeled with synapsin-EGFP via viral transduction and then plated onto human myotubes.
Myotube only cultures did not have α-Bungarotoxin-594 (red) puncta (top left inset). Scale bar =
20µm.
(I) Scatterplot comparing the mean gene expression of starting fibroblasts from a 22 year old
donor (y-axis) and miNs generated from the same individual (x-axis). Plot highlights a selection
of pan-neuronal and fibroblast-specific genes in green text. Blue = log2FC < -2.5 and p < 0.05,
(more abundant in fibroblasts) grey = log2FC >-2.5 and < 2.5 p>.05 (no significant difference),
and red = log2FC > 2.5 and p < 0.05 (more abundant in miNs).
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(J) Scatterplot comparing the mean gene expression of miNs from a 22-year old donor (y-axis)
and Moto-miNs generated from the same individual (x-axis). Plot highlights a selection of panneuronal and motor neuron-specific genes in green text. Blue = log2FC < -2.5 and p < 0.05,
(more abundant in miNs) grey = log2FC >-2.5 and < 2.5 p>.05 (no significant difference), and
red = log2FC > 2.5 and p < 0.05 (more abundant in Moto-miNs).
(K) Moto-miNs generated from multiple donors have lower mRNA levels for fibroblast genes and
higher mRNA levels for motor neuron-specific genes. Moto-miNs were analyzed by qRT-PCR
35 days post-transduction. Human spinal cord RNA served as a positive control (normalized to
42 yr fibroblasts, ΔΔct method). Data are represented as mean ± SEM
(L) MiR-9/9*-124 and ISL1/LHX3 activate the expression of the motor neuron specific miRNA,
miR-218. RNA was isolated from fibroblasts and Moto-miNs 35 days post-transduction and
analyzed by qRT-PCR. Data are represented as mean ± SEM
(M) Moto-miNs retain donor fibroblast HOX gene expression pattern as demonstrated by qRTPCR. Δct method. Data represent Δct values for each biological replicate (3 separate Moto-miN
conversions).
See also Figure S6 and S7.
Next, we used the cell type-specific enrichment analysis tool (CSEA) (Xu et al., 2014) to
test whether the gene expression profile within each population of miNs and Moto-miNs would
be associated with distinct subtypes of in vivo neurons. When queried with a gene list, CSEA
identifies neuronal subtypes that show significant enrichment in genes from the input list through
curated transcriptomic data. Our CSEA analysis of the 100 most enriched genes within MotomiNs identified two subtypes, brainstem motor neurons and spinal motor neurons, to be
significantly associated. No subtype specificity was assigned to the miN transcriptome (Figure

70

S6B). This unbiased bioinformatics approach further supports the motor neuron identity of
converted Moto-miNs.
Lastly, HOX gene expression patterns were compared by qRT-PCR between starting
fibroblasts and Moto-miNs. Interestingly, we observed a high correlation (R2 = 0.88) between
the expression levels of HOX genes before and after conversion within each of the defined
spinal cord regions tested, indicating Moto-miNs retain the positional identity that existed in
original fibroblasts (Figure 7M, S6C).
Transcriptional Activation of ISL1 and LHX3 Genomic Targets
An alternative approach for generating motor neurons is forced expression of NGN2,
ISL1, and LHX3 in human embryonic stem cells (ESCs) (Mazzoni et al., 2013). We compared
the genomic targets of ISL1 and LHX3 identified by Mazzoni et al. through ChIP-seq to genes
whose expression increases in Moto-miNs compared to miNs. Surprisingly, we identified a large
cohort of overlapping genes (323) that include numerous hallmark motor neuron markers
(Figure S7A), suggesting that ISL1/LHX3 activate expression of a core gene regulatory network
that underlies the specification of diverse cellular states towards motor neurons.
Comparison of Moto-miNs to Endogenous Spinal Cord Motor Neurons
The inability to obtain a pure population of motor neurons from humans prevents direct
transcriptional comparisons between Moto-miNs and their human in vivo counterparts.
Therefore, we directly compared Moto-miNs to fully differentiated in vivo mouse motor neurons.
To interrogate the gene expression of motor neurons within the large heterogeneity of cell-types
present in the spinal cord, we performed Translating Ribosomal Affinity Purification (TRAP)
followed by RNA-seq (Figure S7B). The use of two mouse lines expressing EGFP tagged
ribosomes (one line under the pan-neuronal SNAP25 promoter, and the other through the
CHAT promoter), enabled the enrichment and subsequent sequencing of actively transcribed
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mRNA in all neurons and motor neurons within the spinal cord. We also profiled the
transcriptome of the entire spinal cord as an additional ‘pre-IP’ control. Comparisons between
CHAT pre-IP controls and CHAT-TRAP transcripts confirmed significant enrichment of motor
neuron markers (Figure S7C, left) by the TRAP procedure. To further separate motor neuron
enriched genes from common neuronal genes we first normalized CHAT-TRAP and SNAP-25
datasets to their pre-IP controls, then directly compared the normalized gene expression values.
This analysis revealed the co-expression of pan-neuronal genes such as MAP2, NRCAM,
SCN1A and TUBB3 and highly enriched for motor neurons transcripts such as SLC18A3
(VACHT), CHAT and MNX1 (Figure S7C, right). This dataset also serves as a resource for
genes enriched in spinal cord neurons over all SNAP25 expressing neurons within the spinal
cord. To that end, we compared differentially expressed mouse spinal cord motor neuron genes
to genes enriched in Moto-miNs over miNs. We observed a significantly larger overlap between
Moto-miNs and mouse motor neurons than expected by chance (Fisher’s exact test p = 3.522e06), indicating that Moto-miNs and endogenous mouse motor neurons utilize similar genetic
networks. This includes expression of canonical motor neuron markers such as, SLIT2 and
SLIT3, host genes for the motor neuron specific miRNA, miR-218 (Amin et al., 2015) (Figure
S7D). Altogether, our in depth analyses of Moto-miNs at cellular, functional and transcriptomic
levels confirm that co-expression of miR-9/9*-124 and ISL1/LHX3 can directly convert adult
fibroblasts into spinal cord motor neurons.
DISCUSSION
MiRNA-mediated neuronal conversion appears to be distinct from current models of cell
fate reprogramming. Two models of lineage reprogramming have been proposed: one based on
transcription factor cooperativity and positive feedback loops (Jaenisch and Young, 2008; Soufi
et al., 2012; Vierbuchen and Wernig, 2012), and the other proposes that the “on-target” pioneer
activity of a TF initiates and enables additional TFs to assist in cellular conversion (Wapinski et
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al., 2013). In stark contrast, canonical gene regulation by miRNAs requires the removal of
information through translational repression and transcript degradation. This mode of repression
in conjunction with the multitude of anti-neurogenic genes targeted by miR-9/9*-124 suggests
miRNA-mediated reprogramming acts through an alternative mechanism. We propose miR9/9*-124 expression in non-neuronal somatic cells initiates gradual, yet active changes in the
activities of multiple chromatin modifiers while simultaneously repressing anti-neuronal genes
and activating neuronal genes culminating in a binary cell-fate switch. This model is supported
by the rapid cell cycle exit observed upon ectopic miR-9/9*-124 expression, the subsequent
neuronal switching within chromatin modifiers, steady increase in epigenetic and transcriptional
changes, and the time scale in which conversion takes place.
Chromatin Remodeling Accompanies Cell Fate Conversion
In this study, we reveal the surprising potency of miR-9/9*-124 for remodeling chromatin
and altering DNA methylation. Surprisingly, preexisting neuronal loci within the heterochromatic
regions in human fibroblasts opened up in response to miR-9/9*-124. These data suggest the
robustness of miRNA-mediated reprogramming observed in human cells could stem from their
ability to induce epigenetic changes. Cellular processes and identity are governed by the
cumulative action of multiple levels of genome regulation and it is unlikely a single genetic
component downstream of miR-9/9*-124 mediates these changes and ultimately cell fate
conversion. For example, almost every level of epigenetic remodeling participates in the
induction of pluripotency (Takahashi and Yamanaka, 2016). Instructions operating through
multiple levels of genetic and epigenetic regulation are likely required for true cell-fate
conversion. Our thorough characterization of miR-9/9*-124 induced transdifferentiation of
human fibroblasts into functional neurons highlights molecular processes that are critical to cell
fate conversion.
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A Modular Neuronal State
The plastic neuronal platform presented here affords modularity to direct cell fate conversion.
Numerous studies in developmental neuroscience have identified subtype-specific TFs or
terminal selector genes that could be incorporated in neuronal reprogramming technology. Yet,
identifying molecules capable of overcoming the cell-fate barrier present in human somatic cells
and eliciting a permissive environment in which terminal selector genes can act has proven to
be challenging. We demonstrate this property by generating a neuronal population highly
enriched in spinal cord motor neurons from human adult fibroblasts through the coexpression of
miR-9/9*-124, ISL1 and LHX3. Because motor neurons are the major neuronal subtype affected
in Amyotrophic Lateral Sclerosis (ALS) and Spinal Muscular Atrophy (SMA), the robustness and
specificity of neuronal conversion employing miRNAs and motor neuron TFs may pave the way
towards generating patient-specific MNs for disease modeling.
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Figure S5, Related to Figure 6
Identification of Transcription Factors For Defining Motor Neuron Specific Conversion
(A) Candidate motor neuron transcription factors and factor combinations that co-expressed with
miR-9/9*-124 in human fibroblasts.
(B) Immunocytochemistry of adult human fibroblasts overexpressing a non-specific miRNA
(miR-NS) and ISL1/LHX3 (left) or miR-9/9*-124 and ISL1/LHX3 (right) for 35 days. Images
demonstrate the necessity of miR-9/9*-124 for opening the neurogenic potential of human
fibroblasts. Scale bar = 20µm.
(C) Additional representative inward/outward whole-cell currents and repetitive AP waveforms
generated from whole cell patch clamp recordings of Moto-miNs. Images show the patch
clamped cells.
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Figure S6, Related to Figure 7
Addition of ISL1/LHX3 Increases Functional Maturity and Generates Motor Neuron
Transcriptional Network
(A) Peak inward current measured during voltage clamp mode of miNs and Moto-miNs reveals
increased peak inward current in Moto-miNs (-3,189 pA ± 214 pA) compared to miNs (-919 pA
±113 pA). Data are represented as mean ± SEM.
(B) Cell Type-specific Enrichment Analysis (CSEA) tool reveals the top 100 most significantly
expressed genes in miNs do not enrich for defined neuronal subtypes (left), while the top 100
most significantly expressed genes in Moto-miNs are enriched in cholinergic motor neurons in
the brain stem and spinal cord.
(C) HOX gene expression analysis by qRT-PCR in 42 year old female and 56 year old male
donor fibroblasts before and after conversion confirms that Moto-miNs retain donor fibroblast
HOX gene expression patterns. Data represent Δct values for each biological replicate (3 separate
Moto-miN conversions).
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Figure S7, Related to Figure 7
Direct Comparison of Moto-miN Transcriptome to in vivo Mouse Motor Neurons by
Translating Ribosomal Affinity Purification (TRAP) Sequencing.
(A) Venn Diagram depicting the number of ISL1/LHX3 ChiP-seq peaks identified by Mazzoni et
al. during ISL1/LHX3 directed ES to motor neuron differentiation (3,486) and genes enriched in
Moto-miN transcriptome (775). Heatmap shows overlapping activated genes (323) include
hallmark motor neuron markers.
(B) Schematic of TRAP-Seq strategy used to identify transcripts in all neurons (SNAP-25
genetic driver) and motor neurons (CHAT genetic driver) in mouse spinal cord. TRAP is a
method to precipitate actively translated mRNA bound to ribosomes using an antibody to EGFPL10A.
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Materials and Methods
Cell Culture
Cell culture and differentiation was performed as described in Chapter 3.

Myotube Differentiation
Human myotubes were generated by differentiating human myoblasts using defined
culture conditions (Steinbeck et al., 2016). Briefly, human skeletal myoblasts were cultured
according to manufacturers recommendations (HSMM; CC-2580, Lonza) then were plated on
matrigel (.1mg/mL) coated 12mm glass coverslips at a density of 80,000 cells/well. The
following day HSMM’s were differentiated by switching media to skeletal muscle differentiation
media comprised of a 1:1 mixture of DMEM F12 (Gibco) and Complete Neuronal Media + 2%
Horse Serum (Gibco). Every 2 days 75% of the media was replaced with fresh differentiation
media. After 10-14 days of differentiation, Moto-miNs 14 days into conversion and labeled with
synapsin-eGFP via lentiviral transduction were replated onto the established myotubes at a 1:1
ratio (i.e. one 12mm Moto-miN coverslip was replated on top of a 12mm myotube coverslip).
The following day media was changed to complete neuronal media and cells were cultures for 2
weeks. Dox was replenished every two days and half the media was changed every 4 days. After
two weeks cells were fixed with 4% paraformaldehyde and processed for immunocytochemistry
and a-Bungarotoxin staining.
Electrophysiology
Electrophysiology was performed as described in Chapter 3 of this thesis.
MicroArray analyses
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Total RNA was extracted from miNs and Moto-miNs derived from 22 yr old donor
fibroblasts alongside corresponding starting fibroblast controls using TRIzol (Thermo Fisher
Scientific, Waltham, MA) according to the manufacturer’s instruction followed by extraction
using chloroform and then ethanol precipitation. RNA quality was determined by the ratio of
absorbance at 260 nm and 280 nm to be approximately 2.0. Samples for RNA microarray were
then standardly prepped and labeled with Illumina TotalPrep kits (Thermo Fisher Scientific,
Waltham, MA) for Agilent Human 4x44Kv1. Standard hybridization and imagine scanning
procedure were performed according to the manufacturer's protocol at Genome Technology
Access Center at Washington University School of Medicine, St. Louis. The intensity of the
probes was imported into Partek and quantile normalized. Differentially expressed genes were
identified using Partek with a cut-off of adjusted p-value <0.05 and over 2.5 log2 fold expression
change.
Translating ribosome affinity purification (TRAP)
Translating ribosome affinity purification (Heiman et al., 2014) was performed on spinal
cord dissections pooled from 3-4 mice 21 days post birth that were positive for the eGFP-L10A
fusion ribosomal marker protein under either the Chat promoter (Tg(ChatEGFP/Rpl10a)DW167Htz) or the Snap25 promoter (Tg(Snap25-EGFP/Rpl10a)JD362Jdd).
TRAP samples underwent immunopurification for four hours at 4°C. Both TRAP and preimmunopurification control RNA samples were extracted through TRIzol purification, DNase
treatment, and Qiagen RNeasy Mini columns (74104). Quality and quantity of RNA was
assessed using a Bioanalyzer 2100 RNA Pico Chip. Sequencing libraries were amplified using
Nugen Amplification Kit Ovation® RNA Seq System V2 (7102). Genome Technology Access
Center at Washington University in St. Louis performed adapter ligation and sequencing of the
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libraries on the Illumina Hiseq2500. Three replicates of this procedure were analyzed.
Analysis of TRAP RNA-Seq data
RNA-Seq reads were mapped to Ensembl release 76 using STAR (analysis performed
by Genome Technology Access Center at Washington University in St. Louis). For downstream
analyses, only those genes with >1 CPM in at least 3 samples, with an Ensembl gene biotype of
"protein_coding," were retained. For gene symbols mapping to multiple Ensembl gene IDs, only
the ID with the highest number of mapped reads was retained, resulting in a total of 14,009 genes
used for downstream analyses. Using edgeR, read counts were fit to a negative binomial
generalized log-linear model, and a likelihood ratio test was done to determine differential
expression.
Comparative analysis of RNA-Seq and microarray data
For comparative analysis, only probes with a detected call in at least 1 of 6 samples was
retained, resulting in 23,775 probes mapping to a gene symbol. Expression level was then
averaged over all probes for each gene, resulting in a total of 15,333 genes that were used for
comparative analysis, 10,736 of which were also present in the gene set retained from the RNAseq dataset (described above) after CPM filtering. Within the genes retained in both datasets, the
top differentially expressed genes between motor neurons and controls - CHAT IP vs. SNAP25
IP (logFC > 1 and p < 0.05) in the RNA-seq dataset, and Moto-miN vs. miN (logFC >2.5 and p
<.05) in the microarray dataset - were assessed for significant contingency using a one-tailed
Fisher's exact test.
Quantitative PCR
Total RNA was extracted using TRIzol (Invitrogen, USA) according to the
manufacturer's instruction. Reverse-transcribed complementary DNA (cDNA) was synthesized
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from 500ng of RNA with SuperScript III First-Strand Synthesis SuperMix (Invitrogen, USA) or
from 10 ng of RNA for microRNAs expression analyses using specific stem-loop primer probes
from TaqMan MicroRNA Assays (Invitrogen, USA). Subsequently, the cDNA was analyzed on
a StepOnePlus Real-Time PCR System (AB Applied Biosystems, Germany). Expression data
were normalized to housekeeping genes HPRT1 and RNU44 for coding genes and microRNAs,
respectively, and analyzed using the 2-ΔΔCT relative quantification method. The following primers
were utilized:
miRNA qRT-PCR primers
hsa-miR-218 (Thermo Fisher Cat. # 4427975)
RNU-44 (Thermo Fisher Cat. # 4427975)
For primers utilized for mRNA qRT PCR see Table S2.
Overlap with ISL1/LHX3 ChIP Seq
To identify the genes regulated by LHX3 and ISL1 in motor neurons, ISL1- and LHX3ChIP sequencing data (Mazzoni et al., 2013) were used. We selected the regions co-occupied by
ISL and LHX3 during ES to motor neuron differentiation, accounting for 84.2% of peak regions
called in each ChIP-seq data. Based on the peaks co-occupied by ISL1 and LHX3, we annotated
3,486 closest genes with peaks located within 5Kb upstream of TSS and intragenic regions.
Comparing those annotated genes with genes selectively enriched in Moto-miNs vs miNs (log2
fold change=>2.5, p<0.01), identified 323 genes co-occupied by ISL1 and LHX3 that are also
upregulated when miR-9/9*-124 is co-expressed with ISL1/LHX3.
Data Availability
The RNA-seq, ATAC-seq, MeDIP and MRE-seq, and microarray data generated in this study
are: 14 samples, single-ended RNA-seq libraries from starting fibroblasts and miNs throughout
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direct conversion (Days 3, 6 ,10, 20 and 30), 2 replicates per timepoint; 10 pair-ended ATACseq libraries from day 10 Ctrl, day 10 and day 20 miNs, day 20 miNs with shBRG1 and day 20
miNs with an shCtrl, 2 replicates for each timepoint; 6 microarrays from starting fibroblasts, day
35 miNs, and day 35 moto-miNs, 2 replicates per condition; 6 samples of pair-ended MeDIP
libraries and 6 samples of MRE single-ended libraries from day 10, 20, 30 miNs and
corresponding Ctrls. The accession number for the RNA-seq, ATAC-seq, MeDIP and MRE-seq,
and microarray data data reported in this paper is currently being processed and will be
available in the paper cited at the beginning of this chapter. The accession number for the
TRAP-seq data is GEO:GSE93412.

86

Chapter 4: Conclusions and Future
Directions
Significance
One of the greatest barriers in the study and treatment of neuronal disorders and
neurodegenerative diseases has been a lack of patient-specific neuronal subtypes that retain their
age-associated phenotypes. The desire to procure these cells stems from the observation that
many of these neuronal diseases are uniquely human and may require a cellular platform that is
truly representative of the affected species. My thesis has been aimed at meeting this goal
through miRNA-mediated direct conversion technology. While examples of this conversion
modality had been demonstrated at and near the onset of this thesis, that is, the generation of
cortical neurons (Yoo et al., 2011) and of medium spiny neurons (Victor et al., 2014), the general
applicability of this reprogramming paradigm and it’s molecular underpinnings remained
unknown. To this end, I set out to determine whether miRNAs alone, i.e. in the absence of
transcription factors, were capable of trans-differentiating human fibroblasts into functional
neurons. Surprisingly, I found the cellular activities of miR-9/9* and miR-124 were sufficient to
elicit direct neuronal conversion of adult human fibroblasts. More surprisingly, while probing the
identity of converted neurons using gene expression profiling, I discovered these miRNAinduced neurons (miNs) do not possess neuronal subtype identity, suggesting that the activities
of subtype-specific transcription factors utilized in previous studies requires a permissive
environment brought about by the ectopic expression of miR-9/9*-124.
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Exploring this permissive state provided molecular insight into the phenomena of direct
conversion and cell-fate acquisition. In particular, the observation that many neuronal loci
encoding genes important in diverse subtypes open during direct conversion by miR-9/9*-124
but are not expressed provided an epigenetic blueprint for generating other clinically relevant
neuronal subtypes. The further derivation of motor neurons, highlighted in chapter 3, explores
this hypothesis and opens the door to generating other neuronal subtypes.
Altogether, the significance of this work can be separated into two broad findings. First,
despite the short sequence length of miRNAs, they are capable of carrying enough regulatory
information to reprogram cellular identity at epigenetic, transcriptomic, and functional levels.
This is a significant finding as the predominant view of miRNAs revolves around the notion of
“fine-tuning” gene expression. My findings provide a counterpoint to this hypothesis, suggesting
that miRNAs are indeed capable of radically altering gene expression.
The second significant finding, the ectopic expression of miR-9/9*-124 and the motor
neuron transcription factors, ISL1 and LHX3, is sufficient to directly convert adult human
fibroblasts from young and old individuals into motor neurons, provides a platform for motor
neuron disease modeling.

Future Directions
What targets of miR-9/9*-124 are responsible for chromatin remodeling?
To date, miRNAs have not been shown to directly alter local chromatin structure. Thus,
our current understanding of miRNA biology suggests that miR-9/9* and miR-124 likely repress
the expression of chromatin remodeling genes. Indeed, during neuronal development miR-9* and
miR-124 repress the expression of the chromatin regulating BAF-complex subunit, BAF53a.
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This allows for the replacement of BAF53a with BAF53b as neuronal progenitors differentiate
(Yoo et al., 2009). This switch is also observed during miRNA-mediated direct conversion
(unpublished data). However, preventing this switch by overexpressing BAF53A during
conversion does not inhibit neuronal conversion of fibroblasts. Therefore other chromatin
remodeling genes likely play a role in the epigenetic changes observed during conversion. These
genes may not be direct targets of miR-9/9*-124, but may be part of a regulatory cascade
initiated by miR-9/9*-124 overexpression. To identify direct targets of miR-9/9*-124 a technique
such as HITS-CLIP followed by high throughout sequencing could be employed. Coupled with
RNA-SEQ, these two techniques would generate predicted miRNA-mRNA binding and
correlative gene expression changes. To confirm predicted miRNA-target interactions a
luciferase essay could be employed consisting of a luciferase-target-3’UTR fusion that is cotransfected with the predicted miRNA binding partner. Decreases in luciferase activity compared
to a non-target control 3’UTR would validate an interaction between predicted miRNAs and
their targets. To further demonstrate binding the target sequence within the 3’UTR should be
mutated. If this restores luciferase activity it can be inferred that the miRNA of interest binds.
The gene expression studies described in chapter two of this thesis revealed widespread
changes in genes responsible for diverse epigenetic regulatory programs. Many of these genes
are not predicted to be targets of miR-9/9* or miR-124 suggesting their expression changes are
the results of secondary or greater events downstream of these miRNAs. Nonetheless, their role
in reprogramming could be systematically addressed using overexpression and knockdown
studies. For example, I knocked down the expression of BRG1, the catalytic unit of the BAF
chromatin remodeling complex, and performed both ICC and ATAC-seq to test the role of
chromatin remodeling in conversion. Using a scheme such as this, it would be interesting to test
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the individual roles of DNA-methylation writers and readers, histone proteins, histone modifiers,
and chromatin remodeling genes whose expression changes during conversion. Paring down the
list of differentially expressed epigenetic modifiers would represent a key step in understanding
the contribution of each component in reprogramming and would begin to define pathways
required for cell fate conversion. Ultimately, uncovering the genes that create or remove barriers
in reprogramming may offer avenues for increasing the speed and efficiency of direct cell fate
conversion.
Guiding Conversion to other Clinically Relevant Neuronal Subtypes.
Chromatin profiling by ATAC-seq revealed the opening of key subtype-specific loci in
response to miR-9/9*-124 expression. Specifically, dopaminergic neuron markers (TH and
SLC6A3), serotonergic neuron markers (FEV, LMX1B and SLC6A4), GABAergic neuron
markers (SLC6A1, SLC32A1, GAD2), striatal medium spiny neuron marker (PPP1R1B),
glutamatergic neuron markers (GLUL and SLC1A6), and cholinergic or motor neuron markers
(MNX1, CHAT, and SLC5A7) opened but were not expressed. To date, three neuronal subtypes
have been derived using miRNA-mediated direct conversion therefore the probability of
generating neuronal subtypes marked by regions that open in response to miR-9/9*-124 is high.
Towards this goal, I have cloned genes important in the development and specification of
dopaminergic neurons into lentiviral vectors, for example, NURR1, IRX3, OTX2, and LMX1A.
These genes will be expressed individually and in combination with one another in the
background of miR-9/9*-124 and assayed for their ability to activate key dopaminergic markers
such as TH. The acquisition of the dopaminergic fate will be further determined through gene
expression and functional studies. As dopaminergic neurons are the major neuronal subtype
affected in Parkinson’s Disease (PD), the ability generate these cells from patients may provide
a valuable tool in the study of PD. Additionally, establishing multiple cultures of Dopaminergic
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neurons from multiples patients with pathological PD may provide a powerful cellular platform
for drug screening. The output of such a screen would be the production of dopamine.

Does Trans-differentiation Transit Through Analog or Digital Cellular States?
Our time-course RNA and ATAC-seq studies revealed steady increases and decreases of
signal intensity over time suggesting cell fate conversion occurs gradually until terminal
neuronal identity has been acquired. However, at the time these experiments were conducted
only entire populations of cells could be analyzed. RNA-seq in particular required approximately
200,000 cells per condition to yield sufficient quantities of RNA for sequencing. Thus, an
alternative hypothesis that would explain the data is: direct conversion consists of multiple
binary cell fate switches that occur over time non-synchronously towards a final neuronal
identity. Such events would be masked at the population level. To determine whether transdifferentiation is binary or digital, single-cell RNA-seq could be employed at multiple timepoints
during conversion. In collaboration with Dr. Samantha Morris at Washington University in St.
Louis, we have begun working towards this goal. To begin, I collected 10,000 miNs and MotomiNs at 5, 10 15, 20 and 30 days into reprogramming in addition to starting adult human
fibroblasts. After all samples were collected and slowly frozen they were transferred to the
Morris Lab where single-cell libraries were generated. At the time of writing these cells are in
the process of being sequenced. To date, little is known about direct neuronal cell-fate
conversion at the single cell level and the results of this experiment may reveal more definitive
insights into the dynamics of direct cell-fate conversion by removing the mask of population
effects. Further, specific genes that associate with early or failed commitment to the neuronal
fate may constitute accelerants or barriers to the conversion process, respectively. Exploring the
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roles of these genes further in conversion through activation or inhibition studies may provide
methods to increase the efficiency and speed of conversion.

Can Local Cues Guide Subtype Acquisition?
All of our efforts have been aimed at identifying transcription factors capable of guiding
neuronal conversion. The rationale behind this approach is that it is consistent and does not
require complex growth media changes where cocktails of patterning molecules are added at
defined timepoints. However this approach is also limiting in that it relies on known
developmental pathways. It remains unknown if miNs can be terminally differentiated in vivo
using local patterning cues provided by the developing neuroectoderm. By transplanting
fibroblasts into different regions of the developing mouse brain we could simultaneously test the
plasticity of the miRNA-induced neuronal state and identify spatio-temporal cues important in
the establishment of neuronal subtypes. Two different approaches could be used to explore this
question. First, 30 days after injecting miNs into defined regions, mouse brains could be
harvested, sectioned and stained for human specific proteins, subtype specific markers, panneuronal markers, and fibroblast specific proteins. The combination of overlaps between these
markers would reveal if conversion occurred and if subtype identity was acquired.

Can miRNAs illicit in vivo reprogramming?
After optimizing the stereotaxic injection technique, the possibility of converting nonneuronal cells to neurons in vivo could also be examined. The development of such in vivo
reprogramming techniques could provide a therapeutic intervention for neuronal trauma or
disease. The ideal cell to reprogram would be resident astrocytes due to their location and
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tendency to proliferate upon injury. To determine if trans-differentiation occurs, lineage tracing
could be employed whereby a GFAP-Cre mouse line is crossed with a mouse strain that contains
a LoxP flanked STOP codon preceding RFP at the ROSA26 locus. Progeny containing both the
GFAP-Cre and LoxP-STOP-LoxP-RFP alleles would also contain RFP-positive astrocytes.
These mice would then be injected with a GFP-miR-9/9*-124 containing lentivirus at different
locations in the brain. After 2, 4 and 8 weeks mice would be sacrificed and their brains processed
for ICC. Cells that were transduced with the miRNA-containing construct would be identified by
GFP fluorescence. Transduction of astrocytes would be ascertained by presence of GFP and RFP
fluorescence. Co-staining with neuronal markers such as MAP2 or TUJ1 would test whether
GFP/RFP double positive cells converted into neurons. Obtaining proof of principle experiments
using miRNAs would open the gateway to guiding in vivo reprogramming of astrocytes to
defined neuronal subtypes through the addition of transcription factors.

Evaluate the capability of reprogrammed motor neurons to function properly in vivo
If reprogrammed cells are to be used for regenerative therapies they must be able to
function correctly in vivo. In particular, functional recovery mediated by cell replacement
strategies requires that transplanted cells both survive and restore lost connectivity. Several
studies have demonstrated efficient engraftment and functional recovery when using ES and iPS
derived neural progenitors in rat and mouse models of SCI (Lu et al., 2014a). The ability of ex
vivo derived post-mitotic neurons to integrate into the mammalian spinal cord has not been
explored. By supplying all of the required information for conversion genetically, our
reprogramming scheme may be well-suited for delivery of motor neurons, and motor neurons
alone, to sites of injury. Testing this hypothesis would require transplanting moto-miNs into the
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spinal cord of immunodeficient mice at 1, 2, 3, and 4 weeks post-transduction to ascertain the
most favorable timepoint for effective survival. After determining the time of transplantation
that yields the highest amount of neuronal engraftment I would test if transplanted cells can
integrate into the local circuitry by recording from spinal cord slices.
Upon verifying that induced neurons are capable of engrafting into the murine spinal
cord, I would transplant cells into a mouse model of spinal cord injury. Spinal cord injury could
be induced by a dorsal hemisection of the spinal cord in immunodeficient mice, an injury model
that generates stereotyped locomotor deficits such as impaired paw placement during walking
(Zorner et al., 2010). This phenotype has the potential to be rescued by cell transplantation and is
less debilitating than other models of spinal cord injury (Zorner et al., 2010). I would then
examine the extent of cell survival, axon outgrowth, myelination by the host and formation of
synaptic structures 2 and 4 weeks post transplantation. Functional recovery could be assessed by
a battery of locomotor tests and compared to results obtained from controls injected with postmitotic fibroblasts and mock injections.
Approaches in transplanting neural progenitors into the mammalian nervous system have
been met with mixed success (Lu et al., 2014a). Recently, the injection of cells contained within
biomaterial scaffolds and supplemented with neurotrophic factors showed greatly enhanced
survival and growth of transplanted cells (Lu et al., 2014a; Lu et al., 2014b). If poor survival
and/or engraftment of transplanted cells is observed, the use of biomaterial scaffolds and growth
factor supplementation to cell suspensions during injection may need to be explored. Restoring
locomotor activity requires functional integration into the site of injury and surrounding circuit
therefore, if the environment created by dorsal hemisection is too hostile for transplantation, or
the injury too severe, additional models of spinal cord injury may need to be utilized.
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Elucidate the mechanism of guiding reprogramming into motor neurons.
The process by which a fully differentiated fibroblast of mesodermal origin is directly
converted into a functional motor neuron – a highly specialized cell normally arising from
neuroectoderm - remains largely enigmatic. Exploring the etiology of cell fate conversion
presents a unique opportunity in the study of lineage commitment. Simultaneously,
understanding the molecular pathways activated during neural conversion is necessary for the
interpretation of experiments utilizing reprogrammed cells. In addition to determining the
manner in which transcription factors guide reprogramming towards motor neurons, identifying
the logic and function of pro-neural transcription factors within the neurogenic state primed by
miR-9/9*-124 may provide a molecular foundation for choosing transcription factors that may
guide conversion towards additional clinically relevant neural subtypes.
To understand how miR-9/9*-124 and ISL1 and LHX3 are able to reprogram human
fibroblasts into motor neurons, I would conduct a series of ChIP-Seq experiments to determine if
genome binding requires miRNAs and determine the binding locations of each TF. From these
data, I will examine the association of transcription factors with genes important in neurogenesis
and motor neuron development. To explore the possibility that transcription factors are
cooperating with one another, I would ask if transcription factors co-occupy distinct sites. Direct
associations between reprogramming factors could then be tested using Co-IP assays. The
relative contribution of endogenous and exogenous transcription factors within complexes may
be resolved through the use of tagged exogenous genes. I have generated FLAG-HA tagged
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versions of both LHX3 and ISL1 and shown they do not interfere with motor neuron fate
acquisition.
The molecular underpinnings of direct conversion remain largely unexplored. This set of
experiments is designed to gain insights into DNA accessibility, the activation of defined genetic
networks, and the role of transcription factor cooperation in miRNA-mediated reprogramming.
Since little is known about each of these processes in the context of cell fate conversion, these
experiments could shed light on how one cell type is able to change into another without going
through a pluripotent intermediate.

Impact and Closing Remarks
During the course of this dissertation I was able to induce and characterize a miRNAinduced neurogenic state in adult human fibroblasts. The insights provided through this in depth
characterization are critical to further reprogramming efforts in the laboratory and clinic. This
notion is exemplified by the generation of motor neurons directly from adult human fibroblasts.
By further exploring the neurogenic ground state elicited by miRNAs alone, an epigenetic basis
for subtype-specification emerged. Pursuing the hypothesis that miRNAs open the neurogenic
potential of fibroblasts by enabling access to TF binding sites necessary for neuronal subtype
development, led to the derivation of functional motor neurons directly from adult human
fibroblasts.
The impact of this work revolves around the pioneering activities of miR-9/9*-124.
Before this work, it was broadly accepted that miRNAs only “fine tune gene expression.”
Contrary to this idea, I have shown that despite their short sequence length, miRNAs contain
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enough genetic information to radically reprogram the epigenome and transciptome. These
activities lead to the generation of functional neurons, a property that I exploited to derive a
clinically relevant neuronal subtype. Going forward, the method of generating motor neurons
directly from adult human fibroblasts described within this thesis may pave the way to a greater
understanding of motor neuron diseases such as ALS and SMA. Further, the epigenetic blueprint
formed by miRNA overexpression that revealed by ATAC-seq could lead to the generation of
additional neuronal subtypes.
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Supplemental Table 1, Key Resources Table
REAGENT or
RESOURCE
Antibodies
Mouse monoclonal
anti-MAP2
Rabbit polyclonal antiTUBB3B
Chicken polyclonal
anti- NeuN
Mouse monoclonal
anti-SCN1A
Mouse monoclonal
anti-ANKG
Mouse monoclonal
anti-SV2
Mouse monoclonal
anti-MNX1
Goat polyclonal antiCHAT
Mouse monoclonal
anti-SMI-32
Rabbit polyclonal antiKi-67
Mouse monoclonal
anti-Myosin
Mouse monoclonal
anti-NCAM
Mouse monoclonal
anti-5-Methylcytidine
Rabbit polyclonal antiMouse IgG

SOURCE

IDENTIFIER

Sigma-Aldrich

Cat# M4403; RRID: AB_477193

Covance Research
Products Inc
Aves Labs

Cat# PRB-435P-100; RRID: AB_291637

Sigma-Aldrich

Cat# S8809, RRID:AB_477552

UC Davis/NIH
NeuroMab Facility
DSHB

Cat# 73-146, RRID:AB_10697718

DSHB

Cat# 81.5C10, RRID:AB_2145209

Millipore

Cat# AB144P, RRID:AB_2079751

BioLegend

Cat# 801701, RRID:AB_2564642

Abcam

Cat# ab15580, RRID:AB_443209

DSHB

Cat# A4.1025, RRID:AB_528356

Santa Cruz
Biotechnology
Eurogentec

Cat# sc-106, RRID:AB_627128

Jackson
ImmunoResearch
Labs

Cat# 315-001-003, RRID:AB_2340031

Cat# NUN, RRID:AB_2313556

Cat# SV2, RRID:AB_2315386

Cat# BI-MECY-0100, RRID:AB_2616058
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Memorial SloanClone 19C8
Kettering
Monoclonal
Antibody Facility
Monoclonal anti-EGFP Memorial SloanClone 19F7
Kettering
Monoclonal
Antibody Facility
Chemicals, Peptides, and Recombinant Proteins
Fetal bovine serum
Life Technologies
Cat# 10437028
(FBS), qualified, US
Department of
Agriculture (USDA)approved regions
Polybrene
Sigma-Aldrich
Cat# H9268
Neuronal Media
ScienCell
Cat# 1521
Research
Laboratories
Doxycycline hyclate
Sigma-Aldrich
Cat# D9891
(Dox)
Poly-L-ornithine
Sigma-Aldrich
Cat # P4957
solution
Laminin
Sigma-Aldrich
Cat# L2020
Fibronectin,
Sigma-Aldrich
Cat# F4759
Valproic acid (VPA),
Sigma-Aldrich
Cat# 676380
sodium salt,
Dibutyryl-cAMP
Sigma-Aldrich
Cat# D0627
sodium salt,
Retinoic acid (RA)
Sigma-Aldrich
Cat# R2625
Pierce Protein A/G
ThermoFisher
Cat# 20421
Agarose
Scientific
Ampure XP beads
Ampure
Cat# A63880
Monoclonal anti-EGFP

Critical Commercial Assays
RNeasy plus micro kit
Qiagen
SMARTer Ultra Low
Clontech
RNA Kit for Illumina
sequencing
Illumina Genomic DNA Illumina
Sample Prep Kit
ThermoFisher
Illumina TotalPrep
Scientific
kit
Whole Human
Genome Microarray
Kit, 4x44K
QIAquick PCR
Purification Kit
MinElute Gel
Extraction Kit
RNeasy Mini Kit

Cat# 74034
Cat# 635029

Cat# AMIL1791

Agilent
Technologies

Cat# G4112F

Qiagen

Cat# 28104

Qiagen

Cat# 28604

Qiagen

Cat# 74104
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Nugen Amplification
Kit Ovation® RNA‐Seq

NuGEN

Cat# 7102

System V2
Deposited Data

Experimental Models: Mice
Tg(ChatPMID: 19013282
EGFP/Rpl10a)DW167
Htz
Tg(Snap25PMID: 22865458
EGFP/Rpl10a)JD362J
dd
Experimental Models: Cell Lines
Primary 22 year old
NIGMS Human
human adult
Genetic Cell
Repository at the
fibroblasts
Coriell Institute for
Medical Research
Primary 42 year old
Washington
human adult
University in St.
Louis School of
fibroblasts
Medicine iPSC
core facility
Primary 56 year old
NIA Aging Cell
human adult
Repository at the
Coriell Institute for
fibroblasts
Medical Research
Primary 68 year old
NINDS Cell Line
human adult
Repository at the
Coriell Institute for
fibroblasts
Medical Research
Primary neonatal
ATCC
human dermal
fibroblasts
Lenti-X 293LE cell line Clontech
Human skeletal
Lonza
myoblasts (HSMM)
Recombinant DNA
N174
Addgene
N106
Addgene
pMD2.G
Addgene
psPAX2
Addgene
pT-BCL-9/9*-124
Addgene
pT-BCL-NS
(Victor et al., 2014)
LHX3-N174
This paper
ISL1-N174
This paper
pLKO-shBRG1
This Paper

N/A

N/A

GM02171

F09-238

AG04148

ND34769

PCS-201-010

Cat# 632180
Cat# CC-2580

60859
66808
12259
12260
60859
N/A

103

pLKO shEGFP
This Paper
synEGFP
(Victor et al., 2014)
Software and Algorithms
pCLAMP 10 Software
Molecular Devices

N/A
https://www.moleculardevices.com/systems/conventional
-patch-clamp/pclamp-10-software

Graphpad Prism 7

GraphPad
Software Inc

http://www.graphpad.com/

edgeR 3.4

(Robinson et al.,
2010)
(Ritchie et al.,
2015)

https://bioconductor.org/packages/release/bioc/html/edg
eR.html
https://bioconductor.org/packages/release/bioc/html/limm
a.html

(Tripathi et al.,
2015)
N/A
(Zhang et al.,
2013)
(McLean et al.,
2010)
(Heinz et al., 2010)
Felix Krueger,
Babraham
Bioinformatics
(Langmead and
Salzberg, 2012)

http://metascape.org/gp/index.html#/main/step1

limma

Metascape
methylQA
M&M statistical model
GREAT package
HOMER software
TrimGalore, version
0.4.2
bowtie2
Picard Tools

Broad Institute

HTSeq count

(Anders et al.,
2015)

CEAS software
STAR
DREM

(Shin et al., 2009)
(Dobin et al., 2013)
(Schulz et al.,
2012)
(Wise and BarJoseph, 2015)

cDREM

http://methylqa.sourceforge.net/
http://epigenome.wustl.edu/MnM/methylMnM.pdf
http://bejerano.stanford.edu/great/public/html/
http://homer.salk.edu
http://www.bioinformatics.babraham.ac.uk/projects/t
rim_galore/
http://bowtiebio.sourceforge.net/bowtie2/index.shtml
https://broadinstitute.github.io/picard/
http://wwwhuber.embl.de/users/anders/HTSeq/doc/overview.h
tml
http://liulab.dfci.harvard.edu/CEAS/
https://github.com/alexdobin/STAR
http://www.sb.cs.cmu.edu/drem/
http://sb.cs.cmu.edu/cdrem/
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Supplemental Table 2, Primer sequences
used for qRT PCR analysis
Primer
Name
S100A4
FWD
S100A4
REV
VIM FWD
VIM REV
COL13A1
FWD
COL13A1
REV
ChAT FWD
ChAT REV
HB9 FWD
HB9 REV
SLC18A3
FWD
SLC18A3
REV
HOXB4
FWD
HOXB4
REV
HOXC6
FWD
HOXC6
REV
HOXA7
FWD
HOXA7
REV
HOXB7
FWD
HOXB7
REV
HOXC8
FWD
HOXC8
REV
HOXD8
FWD
HOXD8
REV
HOXA9
FWD

Sequence (5'-3')
GATGAGCAACTTGGACAGCAA

CTGGGCTGCTTATCTGGGAAG
AGTCCACTGAGTACCGGAGAC
CATTTCACGCATCTGGCGTTC
GGAGACGGCTATTTTGGGACG
TCCTTGAGTGGAGCTTCCATT
TCAATCATGTCCAGCGAGTC
AACGAGGACGAGCGTTTG
CTCCTACTCGTACCCGCAG
TTGAAGTCGGGCATCTTAGGC

TTCGCCTCTACAGTCCTGTTC
GCTCCTCCGGGTACTTATCG
CGTGAGCACGGTAAACCCC
CGAGCGGATCTTGGTGTTG
ACAGACCTCAATCGCTCAGGA
AGGGGTAAATCTGGATACTGGC
CGTTCCGGGCTTATACAATGT
CTCGTCCGTCTTGTCGCAG
TTCCCAGAACAAACTTCTTGTGC
GCATGTTGAAGGAACTCGGCT
ACCGGCCTATTACGACTGC
TGCTGGTAGCCTGAGTTGGA
GGAAGACAAACCTACAGTCGC
TCCTGGTCAGATAGGGGTTAAAA
TACGTGGACTCGTTCCTGCT
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HOXA9
REV
HOXC9
FWD
HOXC9
REV
HOXD9
FWD
HOXD9
REV
HOXC10
FWD
HOXC10
REV
HOXC11
FWD
HOXC11
REV
HOXD11
FWD
HOXD11
REV
HPRT FWD
HPRT REV

CGTCGCCTTGGACTGGAAG
ACTCGCTCATCTCTCACGACA
GACGGAAAATCGCTACAGTCC
GGACTCGCTTATAGGCCATGA
GCAAAACTACACGAGGCGAA
ACATGCCCTCGCAATGTAACT
GAGAGGTAGGACGGATAGGTG
ATGTTTAACTCGGTCAACCTGG
GCATGTAGTAAGTGCAACTGGG
TCTCCGAGTCCTCGTGGGGA
GCAAAACACCAGCGCCTTCTA

TCCTTGGTCAGGCAGTATAATCC
GTCAAGGGCATATCCTACAACAAA
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